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ABSTRACT 
 
A Proteomic Analysis of Differentiation in the Mammary Epithelium 
 
Laura Therese Strand 
 
While a great deal is known about the changing hormonal environment and the structural 
development of the mammary gland from pregnancy to lactation, very little is known 
about the molecular mechanisms governing differentiation of the mammary epithelium 
into a milk-secreting phenotype. It is important to acknowledge the diversity among the 
mammary glands of different species in order to better understand applications in human 
health and the dairy industry. In this study, we examined global protein expression during 
two states of differentiation in mammary epithelial cells from two species: in vitro 
proliferating and differentiated MAC-T cells (a bovine immortal cell-line), and primary 
mammary epithelial cells isolated from pregnant and lactating mice. When comparing the 
lists of proteins that differed in abundance in the two experiments, we observed many 
similarities in proteins related to structural dynamics and mRNA processing within these 
two mammary epithelial cell types. Intriguingly, we observed several differences in the 
regulation of metabolic proteins, highlighting the distinct pathways by which different 
species probably metabolize energy and synthesize milk components.  
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CHAPTER 1- Literature Review 
 
1.1 Introduction 
 
The words Mammalia and “mammary” are both derived from the Latin word mamma 
meaning “breast”, so it is no surprise that the ability of the mammary gland to provide 
nutrition for neonatal young is a defining factor setting this class of animal apart from 
other vertebrates (Miriam-Webster, 2012). While most mammary related research has 
been conducted in mouse models, it is important to acknowledge the diversity among the 
mammary glands of different species in order to better understand applications in human 
health and the dairy industry. Species-specific differences are not restricted to the 
structure and tissue architecture and include differences in hormonal and metabolic 
regulation of both development and lactation (Capuco, 2002). The purpose of this review 
is to address some of these similarities and divergences as they apply to mammary 
biology from development through lactation. 
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1.2 Mammary Structure/Architecture 
 
The mammary gland is one of few organs in which the majority of development occurs 
postnatally. It also has the unique ability to cycle from structural maturation through the 
production of milk and an apoptotic regression to quiescence. Theoretically, this cycle 
can repeat continuously from first estrus until menopause based on the number of 
offspring and length of time the young are nursed (Knight, 1982).  
 
The mature, non-lactating mammary gland consists mostly of stroma, or a structural 
matrix of support provided by connective tissue, collagen and adipose tissue. Postnatally, 
the fat pad is responsible for not only structural support, but also to provide the mammary 
gland with contact to vasculature, the lymphatic system, lipids and local growth factor 
synthesis (Hovey, 1999). The matrix provides the ideal environment for the branching 
ductal system that makes up the region of the mammary gland responsible for the 
synthesis and secretion of milk. The ductal mammary epithelium is made up of several 
cell type subpopulations: a single layer of squamous, myoepithelial cells surround 
cuboidal, luminal epithelial cells (responsible for synthesis and secretion of milk 
components) and at the terminus of the ducts there are multiple layers of cells with the 
stem-like ability to proliferate further or differentiate into secretory cells upon 
establishment of pregnancy (Gjorevski, 2011). Throughout pregnancy the mammary 
gland develops structurally and epithelial ducts culminate in the formation of alveoli. 
Secretory alveoli are hollow sacs made up internally of a single-layer of cuboidal, 
secretory epithelium connected by tight junctions (Delamaire, 2006). The surrounding 
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outer layers of squamous myoepithelium are not secretory cells, but do have contractile 
capabilities for the purpose of milk movement. 
 
The fat pad surrounding these structures is not an inert element of the mammary gland. It 
has been suggested that the presence of adipose tissue is not only paramount to the 
formation of ductal structures, but also to the total milk yield potential of a gland; the 
number of epithelial cells a gland contains is directly correlated with both the amount of 
adipose tissue in the fat pad and the volume of milk a gland can produce (Hovey, 1999). 
While the stroma of the mammary tissue does not secrete milk components, adipose cells 
and connective tissue do contribute to lactation through structural support and paracrine 
secretion of lactation signals. For example, when estrogen receptor alpha (ER-α) is 
knocked down in the stroma, the epithelium remains under-developed due to the lack of 
hepatocyte growth factor (HGF), which is normally secreted by adipocytes in response to 
the binding of estrogen (E2) to ER-α (Gjorevski, 2011). Recent research indicates that 
this “cross-talk” between the mammary fat pad and the expanding epithelium is necessary 
for the development of the gland as neither stroma nor epithelium will function to its full 
potential without the adjacency of the other (Berry, 2003).  
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1.3 Development  
 
1.3.1 Overview 
 
Although a rudimentary mammary gland exists from birth and expands structurally at 
puberty, the mammary gland has not reached its full potential until it has functionally 
developed milk-making machinery, which may allow a dam to independently support the 
life of her offspring. This chapter will describe the stages of growth within the mammary 
gland from fetal development, through pregnancy, as the gland prepares for the synthesis 
of milk. Lactation, specifically the process of milk synthesis, will be described in depth in 
the following chapter. 
 
The term “mammogenesis” refers to the first stage of functional development during 
pregnancy when the mammary gland begins to prepare structurally for lactation. This 
growth is exponential until parturition and the onset of lactation (Knight, 1982). 
Lactogenesis, or final differentiation of the extensively developed epithelium occurs in 
two stages resulting in the functional milk producing machinery (Tucker, 1981). The first 
stage of change within the epithelium is the increase in milk-related enzyme activity, 
initiation of lipogenesis and the translation of milk proteins such as lactose, caseins, 
alpha-lactalbumin and beta-lactoglobulin. Morpholigically, lactogenesis can be 
distinguished by the formation of intracellular lipid droplets (Brisken, 2006). The second 
stage of lactogenesis involves alveologenesis as tight junctions close between alveolar 
epithelial cells and intracellular milk proteins and lipid droplets are secreted into the 
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alveolar lumen due to the hormonal environment achieved through parturition and 
stimulation (Foster, 1977).  
 
Once lactation has begun, galactopoesis is the term associated with the maintenance of 
lactation for a period long enough to nurture growing offspring and ends in involution, 
the process of apoptosis of secretory cell types through the gradual weaning process and 
the return to a quiescent state (Knight, 1982). Milk composition varies between species, 
between individuals and within individuals but is not significantly affected by frequency 
of milking or volume of milk produced (Delamaire, 2006). Galactopoesis can be 
manipulated and extended through manual milking, a factor upon which the dairy 
industry is based, however, the period of lactation is not indefinite and regardless of 
frequency or milk yield, lactation will peak, regress and eventually cease (Amos, 1985). 
Each of these developmental stages relies on the complex relationship between a variety 
of hormones produced by the ovaries, anterior and posterior pituitary and locally within 
the mammary gland (Perry, 2008).  
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1.3.2 Embryonic Development  
 
In the abdomen of a prenatal mammal, pairs of “placodes” (pre-organ regions of 
thickened epithelium) form within the subcutaneous epithelial layer (Gjorevski, 2011). 
Near the end of gestation, these placodes invaginate the adjacent mesenchyme so that at 
birth, the mammary gland consists of a subcutaneous fat pad containing a very 
rudimentary, branched ductal epitheilum (Mukhina, 2006). Fetal development of the 
epithelium relies heavily on the adjacent inductive mammary mesenchyme that develops 
in the mammalian embryo. However, this stage of development occurs even though the 
rudimentary gland is deficient in receptors for any hormones typically linked with 
postnatal development including estrogen, prolactin, growth hormone, progesterone or 
growth factor receptors such as insulin-like growth factor-1 (IGF-1) and epidermal 
growth factor (EGF) (Hens, 2005). This expansion without hormonal cues is poorly 
understood, but further research may shed light on hormone resistant (i.e. ER-) mammary 
gland cancer (Hens, 2005). The mammary mesenchyme does have the ability to respond 
to androgens and it has been implicated as a possible target for sex hormones in the 
process of sexual dimorphism and cessation of development in the male mammary gland 
(Hovey, 1999). Prior to sexual maturation there is a period of allometric growth 
providing a more complex matrix of structural support for a future functional mammary 
gland (Mukhina, 2006). 
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1.3.3 Pubertal Development 
 
The pubertal transition, termed ductal morphogenesis, allows the ductal system to 
permeate the stroma and fill the fat pad with a more elaborate branched epithelial system 
(Mukhina, 2006). The puberty-associated shift in circulating ovarian hormones, such as 
estrogen, cause extensive proliferation of the mammary gland epithelium to the limits of 
the fat pad and the formation of quiescent boundaries identified as terminal end buds 
(TEB) in mice. TEBs are multilayered structures surrounded by a basement membrane. 
While ducts contain single layers of contractile myoepithelial cells and luminal epithelial 
cells, the “cap” of the TEB contains multiple layers of cells with the stem-like ability to 
proliferate further or differentiate into secretory cells upon establishment of pregnancy 
(Gjorevski, 2011).  
 
In humans, stem cells have been detected in the terminal ducts rather than the caps of 
lobules. Mammary stem cells can become a variety of cell types depending on hormonal 
cues and it has been demonstrated that one mammary stem cell has the ability to re-
populate an entire gland (Gjorevski, 2011). The stem cell populations in the TEB end cap 
of mice express a marker of multipotent stem cells called s-SHIP and the presence of 
stem cells is imperative to the extension of ducts during puberty. Macrophages 
eosinophils and mast cells, three immune cells, are also critical members of the mammary 
gland stroma; without them, stem cells are unable to functionally re-populate the 
mammary gland. While macrophages facilitate the action of stem cells by promoting the 
formation of long collagen fibers around the base of the TEB, which are believed to 
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support ductal elongation, mast cells induce branching of the mammary gland through the 
secretion of serine proteases. The epithelium has been shown to secrete macrophage 
colony-stimulating factor 1 (CSF1) and eotaxin, which may be responsible for the 
recruitment of macrophages and eosinophils to the TEB (Gjorevski, 2011).  
 
It is well-established that ovarian hormones play a role in mammary morphogenesis, but 
there are species-related discrepancies over whether or not normal proliferating 
mammary epithelial cells express ER or progesterone receptor (PR; Capuco, 2002). There 
are two main subtypes of ER: ER-α and ER-β. In humans, cows, and rats, the ER is 
localized to a subpopulation of non-proliferative epithelial cells, but studies in mice have 
shown some evidence of ER+ proliferating cells and stromal cells (Capuco, 2002). 
Estrogen, specifically estradiol (E2), is believed to be the main driver of ductal 
elongation or longitudinal growth during puberty (Stingl, 2011). A review published by 
Brisken, et al. (2006) considered data from several studies to illustrate that ER-α deficient 
mice are completely infertile, but if ER-α is knocked out after sexual maturation, milk 
proteins were still transcribed during pregnancy. These results indicate that ER-α is 
necessary for mammary development during puberty yet may play a smaller role post-
puberty and during lactation (Briskin, 2006). ER-β deficient mice have been shown to 
develop ovarian defects and although they are able to lactate they express under-
developed stroma and reduced milk secretion. Whether or not this is due specifically to 
lack of epithelial E2 signaling or a symptom of general endocrine disruption, which 
would be a likely complication of defective ovaries as E2 is not the only hormone they 
secrete, has not yet been determined (Briskin 2006). Regardless, it is believed that E2 is 
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exhibiting its proliferative effects on the whole epithelium mostly through paracrine 
signaling through induction of amphiregulin secretion by ER-α + cells. Amphiregulin is a 
known cell-growth modulator and shares a significant homology with EGF allowing it to 
bind the EGF receptor (Shoyab, 1989).  
 
Progesterone is the other key ovarian hormone associated with proliferation during 
pubertal development, but it requires the presence of estrogen for maximal effects (Stingl 
2011). In fact, expression of PR is autoregulated by both E2 and progesterone ligand 
binding (Shyamala, 2002). Progesterone receptor abundance in the mammary epithelium 
increases with puberty, but is only detected in approximately 55% of epithelial cells and 
exclusively luminal epithelial cells, not in myoepithelial cells or surrounding stroma 
(Shyamala, 2002). There are two isoforms of PR: PRA and PRB. These receptors are 
derived from transcription of the same gene, differing due to two distinct promoters 
leading to overlapping, but distinct sequences. The longer form (PRB) contains an 
additional 164 amino acids termed the “B-upstream region” at the N-terminal end of the 
protein (Gadkar-Sable, 2005). PRB is the predominant receptor responsible for mediation 
the action of progesterone within the mammary gland during puberty, although PRA is 
up-regulated upon initiation of pregnancy. (Briskin, 2006; Stingl, 2011). Progesterone 
acts by inducing receptor activator for nuclear factor kb ligand (RANKL), which in turn 
binds its receptor (RANK) and induces the side-branching or lateral spread of the ductal 
system (Stingl, 2011). 
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Development of the mammary gland does not rely on ovarian hormones alone, however, 
as evidenced by studies concluding exogenous E2 treatment to be insufficient to rescue 
branching of the mammary epithelium in animals that have had their pituitary gland 
removed. Proliferation of the epithelium requires both growth hormone (GH), secreted by 
the anterior pituitary, and insulin-like growth factor I (IGF-1) expressed by many tissues 
in the body, one of which being the mammary gland (Capuco, 2002). Locally produced 
IGF-1 from stromal cells, and associated binding proteins, may actually mediate the 
exposure and response of the mammary epithelium to circulating GH and E2 (Akers, 
2005). For example, in pubertal rodents, GH treatment has been shown to increase the 
abundance of estrogen receptors as well as stimulating IGF-1 secretion from stromal cells 
(Akers, 2005). The roles of E2, GH and IGF-1 do not end with puberty however. As 
development of the mammary gland progresses, so do the varying roles for these 
hormones.  
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1.3.4 Development During Pregnancy 
 
Gestational hormones stimulate further proliferation of the epithelium and ductal system 
in the pregnant dam. In mouse mammary development the presence of estrogen and its 
binding to nuclear ER-α is required for ductal morphogenesis, while progesterone acts 
through RANK in the same manner as side-branching during puberty to induce tertiary 
branching and alveolar development during pregnancy (Stingl, 2011; Asselin-Labat, 
2010). In mice, alveoli, the hollow sacks lined with secretory mammary epithelium at the 
termini of duct branches, are organized into clusters by day 16.5 of pregnancy (about ¾ 
of gestation period) but do not undergo functional differentiation, or lactogenesis of the 
mammary epithelium until the end of pregnancy, around parturition (Brisken, 2006). 
Milk components synthesized by the epithelial cells collect in the alveoli towards late 
pregnancy and alveoli dilate and grow due to increased pressure. A distinct drop in 
progesterone at parturition signals the secretion of milk components into the alveoli. 
Oxytocin binding its receptors on the myoepithelium causes a contraction, which 
squeezes the swollen alveoli pushing milk out through narrow ducts towards storage 
sinuses (Rudolph, 2011; Lollivier, 2006). When oxytocin binds receptors on the luminal 
epithelial layer of the alveoli, the effect is the acceleration of intracellular secretion of 
casein milk proteins prior to myoepithelial contraction (Lollivier, 2006). Oxytocin in a 
neuro-polypeptide hormone produced and secreted by the posterior pituitary gland under 
many circumstances, one of which being parturition.   
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Prolactin is a pituitary polypeptide hormone detected in pregnant and lactating mammals 
and has a tendency to spike dramatically just before parturition, playing a major role in 
the second stage of lactogenesis (Tucker, 1981). A total deletion of the prolactin gene in 
mice renders females infertile (Gallego, 2001) and without prolactin signaling within the 
mammary epithelium alveogenesis will be incomplete and secretory differentiation will 
fail to occur (Brisken, 2006). Prolactin is the major controller of lactogenic 
differentiation, but it is supported synergistically by metabolic hormones such as growth 
hormone, placental lactogen and adrenocorticotropin to promote milk synthesis and 
secretion (Tucker, 1981). During lactation, prolactin is associated with cell survival, 
glucose metabolism, and MEC-specific lipogenesis and beta-casein expression (Rudolph, 
2011). More recent evidence suggests that the mammary gland itself has capabilities to 
secrete and respond to paracrine and autocrine prolactin, growth hormone, leptin and 
parathyroid hormone related peptide (Brisken, 2006). The prolactin receptor (PRLR) 
signal cascade involves the JAK2/STAT5 pathway, resulting in the activation of several 
transcription factors (including ELF5), which are related to the functional differentiation 
of the mammary gland (Brisken, 2006). Outside of the mammary gland, PRLR activation 
on pancreatic beta-islet cells causes proliferation and insulin secretion, which is related to 
metabolic shifts required for milk production (Brisken, 2006).  
 
There are species related differences in prolactin response. For example, as ruminant 
breeding is closely associated with seasonal day-length, or “photoperiod”, a positive 
effect relationship has been observed in heifers between extended photoperiods and 
elevated prolactin secretion. Specifically, cows that calve in the fall had higher measured 
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prolactin levels mid-pregnancy than cows that calved in the spring (Knight, 2001). 
However, this significant difference in prolactin level during gestation does not 
necessarily correlate to an increase in mammogenesis as in vitro studies have not shown a 
mitogenic effect of prolactin on bovine mammary cells in culture (Knight, 2001).   
 
In swine, the effects of prolactin are most crucial for mammary gland growth between 
days 90 and 109 of a 115 day pregnancy even though the endometrium and placenta do 
not secrete prolactin or placental lactogen as is observed in other species (Trott, 2009). 
Administration of additional prolactin to sows did not contribute to further development 
of the mammary gland, or increased nursing piglet weight leading researchers to believe 
existing prolactin receptors (PRLR) are saturated with the naturally occurring prolactin 
ligand concentration. These findings indicate the prolactin receptor as the limiting factor 
on the effects of prolactin rather than the abundance of the hormone itself (Trott, 2009). 
 
The PRLR does not only interact with prolactin, but also binds growth hormone (Xu, 
2011). Both PRLR and GHR are transmembrane glycoproteins and members of the 
cytokine receptor superfamily of G-coupled protein receptors and are highly conserved 
across species (Xu, 2011). While GH has the ability to bind both receptor types, prolactin 
only binds the PRLR. Both GH and prolactin play crucial roles in the mammary gland 
from development through lactation. 
 
Growth hormone (GH), or somatotropin, is a polypeptide hormone synthesized and 
secreted mostly by the anterior pituitary somatotroph into the peripheral circulation, 
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although more recent evidence suggests other cell types may secrete trace levels for 
autocrine or paracrine signaling (Moffat, 1999). Secretion of GH by the pituitary is 
regulated by peptides of hypothalamic origin. Growth hormone-releasing factor (GHRF) 
is known to stimulate GH secretion while somatostatin inhibits secretion (Etherton, 
1998). GH is made up of 191 amino acids, however, there are species differences and 
even breed differences in amino acid sequence and subsequent structure that make the 
GH of one species biologically inactive in another species due to receptor affinities 
(Etherton, 1998).  
 
While GH has many direct targets, such as muscle and bone, where it contributes to 
growth as its name suggests, its indirect effects are more widespread when GH acts as a 
signal for insulin-like growth factor 1 (IGF-1) secretion. Most systemic IGF-1 originates 
in the liver as it is synthesized and secreted into the blood in response to GH. This 
relationship between GH and IGF-1 is termed the “somatotropic axis” (Raccurt, 2002). 
Some cell types, including those within the mammary gland, can synthesize either or both 
GH and IGF-1 locally, possibly due to reliance upon these growth factors for 
development and function. 
 
IGF-I bioavailability and activity is regulated by insulin-like growth factor binding 
proteins (IGFBP) through reservoir-type storage by extending the half-life of the 
hormone or directing binding to specific tissue sites. Six high-affinity binding proteins 
have been identified and the majority of circulating IGF-I in vivo is bound to IGFBP3, 
IGFBP4 or IGFBP5 (Elis, 2011; Berry, 2001). The differing forms of IGFBP may play 
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distinct roles in mammary development and involution (Berry, 2001). Levels of IGFBPs 
have been demonstrated to vary based on hormonal changes in serum due to exercise, 
diet, pregnancy and age (Elis, 2011). 
 
Growth hormone has long been thought to act indirectly through IGF-1 signaling to 
induce the elongation of ductal branches in the mammary gland as well as contribute to 
the proliferation and differentiation of terminal end buds during puberty (Perry, 2008). 
GH-null rats and GHR-null mice have both previously been shown to undergo impaired 
mammary development in comparison to respective wild-types (Mukhina, 2006; Perry, 
2008). This effect has been supported by one study that antagonized the natural GH 
signal resulting in impaired mammary development in mice, and the rescue of mammary 
development in GH-null rats by administering exogenous GH (Perry, 2008). These 
studies indicate a necessary relationship between GH and the proliferation stage of the 
mammary gland although the authors did not determine whether or not there may be a 
direct relationship versus mediation by IGF-1 alone. 
 
With a structure very similar to growth hormone, placental lactogen (a.k.a chorionic 
somatomammotropin) is secreted by the placenta and is known to stimulate lipolysis and 
antagonize insulin action allowing for more energy availability for the fetus while 
contributing to mammary development during pregnancy (Picciano, 2003). 
 
At the end of pregnancy, the normal mammary gland has undergone all preparation to 
feed the growing offspring, and the act of parturition itself and the suckling of new young 
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both contribute to the ejection of stored milk. The specifics of which will be explored 
further in the following section. 
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1.4 Lactogenesis 
 
1.4.1 Overview 
 
Although the composition of milk varies depending on a variety of factors including 
species, breed, individual and even milking event, milk is generally made up of water 
containing lipids, proteins, amino acids, vitamins, minerals, immunoglobulins, hormones, 
cytokines, enzymes and other peptides essential for the growth of mammalian young 
(Haug, 2007). While lactose and most minerals are water soluble, lipids exit the cell 
emulsified in coated globules and milk proteins are suspeneded in micelles with calcium 
or salts (Haug, 2007). Early mammary secretion (first 3-5 days post partum in humans) is 
termed “colostrum”, a viscous substance rich in minerals, antibodies and other immune 
factors including lactoferrin and secretory immunoglobulin A (Picciano, 2003). White 
blood cells and specifically B and T lymphocytes within colostrum and mature milk 
contribute significantly to building the immune system of the neonate (Larson, 1979). As 
colostrum transitions to mature milk, there is a decrease in mineral and protein content 
and an increase in water and lactose (Picciano, 2003).  
 
Major differences between ruminant and non-ruminant milk production are due in part to 
the dietary differences between species and the contribution of gastrointestinal flora to 
the circulating nutrient pool available to the mammary gland for milk synthesis. While 
most ruminants naturally consume large quantities of feed high in cellulosic, indigestible 
fiber, microbe populations maintained within the anaerobic rumen environment ferment 
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these carbohydrates into volatile fatty acids (VFA) which are absorbed by the host 
ruminant. As microbes expire they are digested by the animal providing an additional 
source of protein to be absorbed in the gastro intestinal (GI) tract (Van Soest, 1994). In 
general, ruminant animals maintain much lower levels of circulating glucose compared to 
non-ruminants due to this dietary process and therefore use VFAs as an alternative form 
of energy wherever possible. For example, during late gestation 55% of ruminant fetal 
energy is taken up as amino acids while only 30-35% is supplied by glucose (and 
subsequent metabolite, lactate) (Bell, 2000). The remaining energy is supplied in the 
form of acetate. Depending on their diet, rodents and other hind-gut fermenters, also have 
the ability to absorb VFAs produced through the activity of caecal microbe populations 
and may also contribute microbial VFAs to milk synthesis (Morishita, 1996). 
 
High-yielding dairy cows ingest less energy than they expend at the start of milk 
production, classifying this state as a negative-energy-balance (Kuhla, 2011). 
Consequently, they must mobilize fat, glycogen, and muscle protein to meet energy out-
put requirements and the breakdown of skeletal muscle becomes the primary source for 
essential amino acids (EAAs). Loss of body protein in early lactation may amount to 
approximately 20 kg per day in some dairy cows (Kuhla, 2011). It has been suggested 
that the free AAs in circulation due to skeletal muscle breakdown may trigger a loss of 
appetite, even in a state of negative energy balance. Feed intake in dairy cattle decreases 
as they approach parturition, and only slowly increases to finally reach a state of positive-
energy-balance after 8 to 12 weeks of lactation (Bauman, 2000). 
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Rodents on the other hand experience a gradual increase in the lactational demands of 
nursing pups, and so feed intake is gradually increased proportionally to the growth and 
number of pups. This increase can be up to 300-400% compared to feed intake prior to 
pregnancy and lactation, but can meet the nutritional requirements for the output without 
requiring the loss of body stores as observed in ruminant species (Bauman, 2000). 
Human young demand a comparatively modest volume of milk for adequate nutrition 
when compared to other mammalian species; normal human lactation should rarely result 
in a negative-energy-balance (Bauman, 2000). 
 
On the cellular level however, milk ejection is rather similar between species. Cuboidal, 
secretory epithelial cells form the closest contact possible between adjacent cells, which 
are termed tight junctions. Tight junctions function both as a barrier and as a gate, as 
during lactation they mediate the transport of small molecules and ions between cells 
while maintaining polarity within the cells for the maintenance of ion pumps and 
channels (Delamaire, 2006). Ejection of milk components from the epithelium is a result 
of osmotic pressure build-up as lactose and other minerals accumulate, drawing 
additional water into the cells. There are gap junctions between adjacent cells that may 
allow for some exchange of small molecular signal proteins, contributing to the 
synchronized ejection of milk components from the epithelium into the lumen of the 
alveolus (Larson, 1979). 
 
As milking decreases, or weaning occurs, the composition of milk contains fewer 
nutrients than milk from earlier lactation (Delamaire, 2006).  This gradual change is 
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caused by the “loosening” of the tight junctions allowing for greater permeability and a 
decreased uptake of milk precursors by epithelial cells. The synthesis of individual milk 
constituents will be discussed further within this review. 
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1.4.2 Protein Synthesis 
 
A crucial component of milk for the growth and survival of young is the supply of amino 
acids, minerals and antibodies delivered by milk proteins. The majority of milk protein 
consists of four casein proteins (α-s1, α-s2, β and κ) and whey proteins (α-lactalbumin and 
β-lactoglobulin). Although less abundant, milk also contains transferrin and lactoferrin, 
immunoglobulin IgA, lysozyme, and serum albumin (Jenness, 1979). Bovine milk is 
widely commercialized as a nutritious food source for human consumption and contains 
an average of 32g of protein per liter, 80% of which is casein. Casein forms micelles with 
calcium and phosphorus for efficient transport of these minerals to the digestive system 
once ingested (Haug, 2007). The most abundant casein protein in human breast milk is 
homologous with the bovine milk protein beta-casein (Jenness, 1979).  
 
Blood proteins and milk protein precursors (i.e. amino acids) enter the secretory, lobular 
mammary epithelial cells through the basal membrane, which is in direct contact with the 
basement membrane of the extracellular matrix separating the epithelium from the blood 
stream (Larson, 1979). Milk proteins are coded for by messenger RNA (mRNA) exported 
from the nucleus and capped on the 5’ end. At the 3’ end of milk protein mRNA there is a 
tail of multiple adenylyl nucleotides (a “poly (A)-tail”), which aids in translation and 
protects against mRNA degradation (Rhoads, 2007). Each set of 3 nucleotides codes for 
an individual amino acid, which is recruited to the ribosome bound to a complementary 
transfer RNA (tRNA). The ribosome translates mRNA into peptide chains of amino acids 
on the endoplasmic reticulum. From here, long, polypeptide chains are transported to the 
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Golgi apparatus where glycosylation and phosphorylation occur along with the coupling 
of calcium to casein micelles. Tertiary folding and accumulation of micelle structure is 
completed before fully formed milk proteins are ejected through the apical membrane of 
the epithelial cell into the lumen of the alveolus through transport by secretory vesicles 
(Larson, 1979).  
 
Lactogenic hormones (prolactin, insulin, glucocorticoids) have great control over the 
regulation protein synthesis by the mammary gland not only by stimulating transcription 
of mRNA coding for milk protein genes, but also by stabilizing mRNA and extending the 
half-life for more efficient translation (Rhoads, 2007).  The translation of milk proteins is 
then stimulated by a synergy between available amino acids and insulin and prolactin 
signaling (Rhoads, 2007). In the presence of lactogenic hormones, the mammary 
epithelial cell selectively polyadenylates milk protein mRNA in the cytoplasm elongating 
the poly(A)-tail for enhanced translation (Rhoads, 2007).  
 
The availability of amino acids to the mammary gland for milk synthesis is based 
primarily on dietary intake, but also gastrointestinal and hepatic utilization of amino acids 
(Bequette, 1997). During lactation, ruminants specifically experience a surprisingly low 
efficiency of dietary amino acid conversion to milk protein. In fact, the levels of certain 
free-form essential amino acids (EAA) absorbed from the circulation by the mammary 
gland have been measured to be insufficient for the amount of milk protein secreted. This 
deficiency must be met by breaking down formed proteins that contain the necessary 
EAAs, sometimes sacrificing muscle tissue (Bequette, 1997). Other amino acids, whose 
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absorption is greater than output as milk protein --leucine is an example-- are not taken 
from protein-bound sources (Bequette, 1997). When additional free-form dietary amino 
acids are administered, the mammary gland has a higher affinity for these sources than 
the protein-bound sources, which require extra energy to break down. This illustrates the 
adaptability of the gland to changes in supply and demand. 
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1.4.3 Lactose Synthesis 
 
The disaccharide lactose is the main osmotic agent drawing water into milk and due to 
this, lactose synthesis contributes significantly to milk yield. Lactose is the most 
abundant carbohydrate found in milk contributing nearly half of the caloric content 
required by the infant and synthesized from glucose and galactose within the Golgi 
apparatus (Sunehag, 2003; Anderson 2007). The synthesis of this particular sugar is 
unique to the mammary epithelial cell due to the expression and activity of lactose 
synthetase, a heterodimer made from milk protein alpha-lactalbumin and its interaction 
with Golgi-bound glycosyltransferase beta-1,4-galactosyltransferase (Anderson, 2007; 
Shaper, 1998). In dairy cattle, 55-70% of glucose taken up by the mammary gland is used 
for the synthesis of lactose (Guinard-Flament, 2006). Eighty to 85% of the carbon in 
bovine milk lactose is derived from glucose because more than half of the galactose 
required for lactose synthesis is actually a converted product of glycolysis. This 
production involves conversion of glucose 6-phosphate to galactose by the enzymes 
glucose phosphorylase and glucose 4 epimerase (Sunehag, 2003). Additional galactose 
can be synthesized from glycerol, and some studies suggest the lactating mammary gland 
has the enzymatic capacity to produce glucose-6-phosphate from other 3-carbon 
substrates, a process characterized within the human breast and termed hexoneogenesis 
(Sunehag 2003). The percentage of plasma glucose-derived lactose is higher in non-
ruminants with greater dietary glucose intake and during a fed state as opposed to fasting 
(Anderson, 2007). 
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Glucose pays a critical role in lactation for both ruminants and non-ruminants although 
the availability of glucose to the gastrointestinal tract, and subsequently the circulation, is 
much lower in the ruminant due to rumen fermentation. In addition, the fate of glucose in 
the mammary epithelial cell differs slightly between the two mammalian metabolic 
systems. Overall, this monosaccharide is necessary for the synthesis of lactose, metabolic 
energy (ATP production), glycerol production for de novo fatty acid synthesis, and 
NADPH production through the pentose phosphate pathway (Van Soest, 1994; Guinard-
Flament, 2006). Additionally in non-ruminants, glucose is the main precursor fatty acid 
synthesis as will be discussed in chapter 1.3.4. 
 
Because the mammary epithelium does not possess the necessary enzymes for 
gluconeogenesis, all glucose utilized by this organ must be taken up from the circulation. 
Glucose enters the mammary epithelial cell via the GLUT1 transporter, an insulin 
independent transporter. In dairy cows, the mammary gland has been known to use up to 
85% of total circulating glucose, although published research states that the GLUT1 
transporters on ruminant mammary epithelial cells are probably never saturated under 
normal physiological conditions (Zhao, 1996). Once inside the cell, if directed towards 
use as an energy source, glucose is converted to glucose-6-phosphate by the enzyme 
hexokinase (Rudolph, 2011; Salway, 1994). From this point, glucose-6-phosphate can be 
a precursor for either glycolysis and the tricarboxylic acid cycle (TCA) or the pentose 
phosphate pathway providing energy for fatty acid synthesis.  
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1.4.4 Lipid Synthesis 
 
Although “reduced-fat” and “non-fat” dairy products have increased in popularity for the 
adult human consumer, the neonate would not survive without milk fat. The 
concentration of fat in milk varies between species and the needs of their young, but on 
average, 95-98% of the lipid content in milk is triacylglycerols made up of fatty acids of 
differing lengths and levels of saturation (Haug, 2007). The remaining 2-5% of lipids are 
made up of diacylglycerol, cholesterol, phospholipids and free fatty acids (Haug, 2007). 
Triacylglycerol is synthesized by the joining of long or short chain fatty acids to a 
glycerol backbone. Once a molecule is complete it combines with other fully-formed 
TAG to make lipid globules that increase in size as they are translocated to the apical 
surface of the epithelial cell where they are surrounded by the apical membrane which is 
pinched off and emulsified in milk (Larson, 1979). Milk fat can be made from fatty acids 
stored in adipose tissue, diet, or through de novo synthesis and carried through the 
circulation to the mammary epithelium bound to albumin or very low-density 
lipoproteins (VLDL). Ruminant milk is unique in that it contains a high proportion of 
short-chain (between 4 and 10 carbons) fatty acids even though these forms are not found 
in non-ruminant milk or feed. This means ruminant milk fat is more often derived from 
de novo synthesis or the desaturation of free long-chain fatty acids (Bauman, 2011). In 
the non-ruminant mammal, glucose is the primary source of both glycerol and fatty acid 
synthesis (Anderson, 2007). 
 
Lipogenesis, or more specifically, de novo synthesis of fatty acids occurs mainly in the 
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liver, adipose tissue and mammary gland of a lactating mammal (Laliotis, 2010). The 
main precursor for this pathway is acetyl-coA, however, the source of acetyl-coA and the 
primary location of lipogenesis is species specific. In humans, and most non-ruminant 
animals, the majority of fatty acid synthesis occurs in the liver. Conversely, the low-
glucose ruminant diet causes the ruminant to rely on the liver primarily for its 
gluconeogenic capabilities, and the adipose tissue and mammary gland (during lactation) 
are the sites, for the majority of de novo fatty acid synthesis (Laliotis, 2010). The main 
energy sources delivered to the gut post-fermentation by the rumen are the volatile fatty 
acids (VFA) acetate, propionate, and butyrate. Acetate is the basic building block for 
fatty acid synthesis in ruminants, which requires NADPH as a reducing agent (Bauman, 
2011). 
 
As illustrated in figure 1, non-ruminants can utilize glucose for fatty acid synthesis. 
Acetate and pyruvate can be oxidized to acetyl-coA within the mitochondria and 
converted to citrate in order to be transported out of the mitochondria by the 
citrate/tricarboxylate carrier (CiC). Through the action of citrate lyase, citrate can be 
broken down into acetyl-coA and oxaloacetate outside of the mitochondria. Acetyl CoA 
may then be used for fatty acid synthesis and oxaloacetate can then be converted to 
malate and cycled back to pyruvate through the action of malate dehydrogenase. The 
reaction producing pyruvate from malate provides an additional source of NAPDH for 
the non-ruminant, but as illustrated in figure 2a, this enzyme is not active in the ruminant 
mammary epithelial cell.  
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Another difference in the ability of ruminant mammary epithelial cells to produce 
NADPH is the lack of citrate lyase activity. As illustrated in figure 2b, citrate cannot be 
converted to acetyl CoA or oxaloactetate, and therefore, there is no complete 
pyruvate/malate cycle. Due to this factor, the TCA cycle cannot contribute to fatty acid 
synthesis in the ruminant and NADPH must be produced by isocitrate dehydrogenase 
(IDH) activity and the conversion of isocitrate to alpha-ketoglutarate in the cytosol or by 
the pentose phosphate pathway (Salway, 1994). 
 
Figure 1. Fatty Acid Synthesis
This figure illustrates the alternate pathways and carbon sources utilized by ruminant 
versus non-ruminant animals for eventual participation in de novo fatty acid synthesis 
within the mammary epithelial ce
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ll. 
 
Figure 2. NADPH Production
NADPH is produced through the action of the pentose phosphate pathway, malate 
dehydrogenase and isocitrate dehydrogenase, in the non
cell. Ruminant animals do not express the enzymes necessar
illustrated in the bottom figure with crossed
ruminant mammary epithelial cell must be produced via isocitrate dehydrogenase activity 
and to a lesser degree, the pentose phosphate pat
 
a. 
  
b. 
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31 
1.4.4.1 Pentose Phosphate Pathway 
 
The pentose phosphate pathway is active only in the liver, adipose, lactating mammary 
gland, adrenal cortex and red blood cells in the mammal (Mellenberger, 2009). When 
glucose is present in abundance and glycogen stores are full, excess glucose will be 
stored as fat; a process which requires the products of the pentose phosphate pathway. 
Mammary epithelial cells must also take advantage of this pathway when demand for 
milk fat becomes a metabolic priority during lactation (Salway, 1994). The pentose 
phosphate pathway produces NADPH, which can be used for biosynthesis of fatty acids 
and cholesterol.  
 
Glucose 6-phosphate enters the pentose phosphate pathway and is oxidized by glucose-6-
phosphate dehydrogenase to form 6-phosphoglucono-delta-lactone and NADPH. 
Lactonase further hydrolyses the product into 6-phosphogluconate, which is oxidized by 
6-phosphogluconate dehydrogenase to ribulose 5-phosphate and gives off CO2 and an 
additional NADPH. This phase of the pathway is irreversible, the final product, ribose 5-
phosphate, can accumulate, and three molecules of ribose 5-phosphate be converted into 
two molecules of fructose 6-phosphate and one molecule glyceraldehyde 3-phosphate. 
Fructose 6-phosphate can be converted back to glucose 6-phosphate for re-entry into the 
pentose phosphate pathway cyclically or re-entry to the glycolytic pathway. This pathway 
is regulated by the availability of NADP+, which is readily abundant during fatty acid 
synthesis, where NADPH is reduced (Mellenberger, 2009). Ruminant mammary tissue 
only undergoes an increase in pentose phosphate activity of about 3 fold, while pentose 
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phosphate activity in rodent mammary glands has been shown to increase by 15-80 fold 
(Mellenberger, 2009). This is probably due to glucose being the substrate upon which this 
pathway relies, and the relatively low levels of circulating glucose in the ruminant 
system. 
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1.5 Mammary Gland Models 
 
Due to the endless complexity of a whole animal system, in vitro modeling has become 
the preeminant approach to studying cellular function in a controlled manner that can be 
manipulated experimentally (Matitashvili, 1997). Among the most commonly employed 
mammary models are explant tissue, primary cell and immortal cell line cultures. 
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1.5.1 Explant Culture 
 
An explant culture consists of a small, three-dimensional tissue-sample that may be 
excised from the mammary gland through biopsy or immediately following slaughter. As 
a model, the explant is an excellent way to observe the interactions between all of the cell 
types within the gland that may depend on structural relationships to function similarly to 
in vivo (Keys, 1997). In addition, an effect observed in vivo can be validated in culture 
when that tissue is separated from circulating ligands and systemic signals (Telang, 
1989). Some drawbacks to explant culture (excluding xenografts) are: (a) the short life of 
the tissue in culture as they are only viable for a few day at most (Keys, 1997); (b) the 
mix of cell types within an explant, making study of the epithelium exclusively 
impossible, and knowing the proportion of epithelial cells in the explant is a challenge; 
(c) explants cannot be frozen cryogenically, so some experiments are not repeatable over 
time with samples from a single isolation event. While explants from rodent mammary 
glands have been used in experiments for over 50 years, conducting successful explant 
studies with ruminant mammary tissue has presented a much greater challenge, and is 
more narrowly studied (Matitashvili, 1997). 
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1.5.2 Primary Cells 
 
Primary cell cultures consist of a specific cell type isolated from tissue that may be 
excised from an animal under the same conditions as an explant. Once tissue is excised it 
can be minced, digested and strained to a single cell suspension, at which point differing 
cell types can be separated through a variety of protocols including gradient cetrifugation 
or plate adhesion incubation periods (Smalley, 2010). Primary cells can be isolated from 
animals in different stages of development (i.e. pregnancy versus lactation) to control for 
differences based on starting stage of the mammary cell (Matitashvili, 1997). Other 
advantages to using primary cell culture are: (a) the ability to study a single cell type; (b) 
primary cells secrete proteins and lipids directly into media which can then be measured 
quantitatively; (c) primary cells can proliferate for a greater volume of samples and can 
be kept in culture for extended periods provided the right combination of growth factors 
and nutrients; (d) primary cells can be cryogenically frozen and used for future research 
or to repeat an experiment at a later time, even with cells isolated from the same animal 
(Keys, 1997). A few drawbacks are: (a) the necessity for validation that the intended cell 
type was indeed the one isolated and cultured and the likelihood of a small percentage of 
contaminating mesenchymal cells (Matitashvili, 1997); (b) an environment unlike the in 
vivo environment, cryopreservation and extended passaging of cells may cause a change 
in the cells morphology and function (Keys, 1997). Morphology and secretory activity 
may also be affected by whether primary cells are plated on plastic culture dishes, 
artificial extracellular matrices, or attached collagen gel (Matitashvili, 1997). 
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1.5.3 Immortal Cell Lines 
 
An alternative to these methods is the culture of an immortalized mammary cell line. 
Several mammary epithelial cell lines from a variety of species have been used in 
mammary biology research and all originate from primary cell isolation of normal or 
tumor cell types (Matitashvili, 1997).  
 
Commonly studied are immortal mammary epithelial cell lines that originate from murine 
species. The COMMA-1D cell line, for example, has been used extensively in mammary 
gland reasearch and was initially isolated from mid-pregnant BALB/c mice. Although 
this line has been passaged continuously, it was never transformed and the mechanism 
behind its immortality is somewhat unknown, even by scientists who initially 
characterized the line (Danielson, 1984). These cells were assumed to be proginator cells, 
or stem cells and due to their ability to populate a cleared fat pad with a normal 
mammary structure as well as their inducible casein production in vitro they are 
considered an excellent in vitro model for the mouse mammary epithelium (Danielson, 
1984). The HC11 cell clone was later isolated from the COMMA-1D line due to the need 
for a strain that would grow without an extracellular matrix or co-cultivation with other 
cell types. The success of this isolation was confirmed through the expression of beta-
casein dependent upon treatment with prolactin when cultured on plastic (Ball, 1988).  
 
Although there are many established cell lines that originate from mice, fewer lines are 
readily available for bovine studies. One cell line, MAC-T, was developed by Huynh et 
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al. through the stable transfection of alveolar epithelial cells from a mid-pregnant 
Holstein heifer with the simian virus (SV)-40 large T anigen (TAg) (Huynh, 1991). The 
SV-40 TAg is an oncoprotein (cancer causing protein) that inhibits the activity of tumor 
suppressing factors p53 and retinoblastoma allowing the host cells to proliferate 
indefinitely (Ali, 2001). MAC-T cells have the ability to differentiate to a “lactating” 
phenotype when induced with a lactation medium including dexamethazone, insulin and 
prolactin, defined by the fact that they can secrete milk proteins in culture (Huynh, 1991).  
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1.6 Lactation & Breast Cancer 
  
Breast cancer accounts for 1 in 4 female cancers and is by far the most common cancer in 
women worldwide with rising incidence (Siewit, 2009; Moreira, 2010). Epidemiological 
studies have recognized a relationship between early age of first full-term pregnancy and 
total number of pregnancies with a reduced risk of breast cancer for nearly a half-century 
(MacMahon, 1970). More recently, the relationship between mammary gland 
development, lactation and its subsequent preventative effects are being studied in 
clinical settings (Yogi, 2012). Although the post-lactational breast regresses to a state 
very similar to the nulliparous breast, studies have shown that pregnancy induces some 
permanent changes in gene expression within the mammary gland, specifically related to 
DNA damage repair, enhanced immunity, and decreased cell proliferation (Russo, 2005; 
Yogi, 2012). The end of lactation signals a regression of the functional gland that 
includes massive apoptosis leaving just a few stem cells to repopulate the gland upon 
future pregnancy. These parous stem cells have been exposed to different hormones and 
structural changes, making them epigenetically different and functionally different than 
the stem cells populating the mammary gland during first pregnancy (Russo, 2005). 
Additionally, mouse studies have shown that an early pregnancy can reduce the total 
number of stem cells within the mammary gland without impairing their ability to 
repopulate the gland (Visvader, 2009). 
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1.6.1 Breast Cancer Biomarkers 
 
Early detection and classification of breast cancer greatly improves the odds of the 
survival of a patient, which makes the simplicity of screening and the identification of 
biomarkers extremely important (Ou, 2008). The term “biomarker” is described by the 
National Institute of Health as a cellular event in which expression signifies a specific 
phenotype, in this case, cancer (NIH, 2011). Interestingly, transcription factor GATA-3 
has been implicated as a gene driving luminal cell differentiation within the mammary 
epithelium and expression of GATA-3 is also a biomarker and a determinant of breast 
cancer patient prognosis (Visvader, 2009). With higher levels of Gata-3 a tumor is more 
likely to respond to treatment as it is associated with a more differentiated state and is 
less likely to metastasize.  
 
There are numerous ways in which biomarkers may be identified and each methodology 
has both strengths and limitations. Methods based on existing hypotheses tend to favor a 
narrower scope, focusing on a specific pathway thought to be affected by a carcinogenic 
introduction.  For example, many tumor cells exhibit the “Warburg effect” or the 
heightened consumption of glucose causing a build-up of lactate through anerobic 
gycolysis and reduced use of the TCA cycle (Levine, 2010). Since its discovery in 1926, 
this pathway has been compared between tumor cells and normal cells of the same tissue 
to implicate a few oncogenes and tumor-suppressing genes. A deeper understanding of 
these genes implicated may be useful in developing targeted gene therapies in cancer 
treatment (Levine, 2010). A major drawback to studying this narrow scope of genes on 
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the transcriptional level is the lack of correlation between gene expression and protein 
expression, with recorded differences as high as 30-fold (Ou, 2008). Additionally, there 
are post-translational modifications and cellular localization events that totally change the 
function of a molecule, which are not detected by quantitative mRNA expression profiles. 
An alternative method is to employ a discovery technology or hypothesis-generating 
approach such as proteomics, the results of which can be compared with transcriptional 
data to implicate specific genetic biomarkers. 
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1.7 Summary 
 
The exocrine mammary gland is an organ of great complexity with a synchronous 
relationship to endocrinology and metabolism. It is this systemic involvement makes this 
organ, and the cells of which it is comprised quite difficult to study exclusively, yet a 
deeper understanding may provide insight into the treatment and prevention of cancer and 
the nutritional optimization and production efficiency of the dairy industry. Instead of 
approaching the holes in our knowledge of this gland by focusing on the pathways we 
already expect to be involved, research into development of the mammary gland may 
benefit from a more global approach. As “omic” technologies are improving rapidly, and 
transcript and protein databases are expanding with new research, our lab has developed a 
curiosity in the application of these technologies to gain further knowledge on 
differentiation of the mammary epithelium.  
 
Through the application of literature review to our experimental analysis, we hope to 
provide novel insight into cellular mechanisms that may be involved in the differentiation 
of mammary epithelial cells from a proliferation stage to lactation. Moreover, we hope to 
approach this question by taking into consideration the whole-animal species differences, 
from diet and metabolism to needs of the young that may be applicable to the developing 
mammary epithelial cell. 
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CHAPTER 2 – Proteomic Analysis of Differentiation in the MAC-T Cell Line 
 
2.1 Introduction 
 
Previous research within our lab has demonstrated an effect of growth hormone (GH) on 
the proteomic profile of differentiated bovine mammary epithelial cells (MEC) of the 
immortal cell line MAC-T*. MAC-T cells can be differentiated in vitro through treatment 
with a classic lactation medium containing dexamethosone, insulin and prolactin at the 
point of confluence (when cells completely coat the surface upon which they are plated) 
and are known to retain many of the characteristics of bovine MEC (Huynh, 1991). The 
proteins that changed in response to GH treatment were related to glucose metabolism, 
NADPH production, cytoskeletal changes and RNA processing which led us to believe 
the effect of GH may cause changes that are similar to those which occur during 
differentiation events. If true, GH would be implicated as a possible factor in mammary 
epithelial cell differentiation, which contradicts current dogma of the role of GH within 
the mammary gland (Zhou, 2008).  
  
In order to assess the results of the GH study and its association with differentiation, there 
must be a control study with which to compare. The obvious control is to observe 
changes in global protein expression that occur within the epithelium over the process of 
differentiation in MAC-T without growth hormone treatment. We went about this 
observation by comparing protein extracts isolated from cells still proliferating in vitro 
                                                 
*
 Thesis research by Tasha Johnson, 2010. Publication in progress. 
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and cells that had been differentiated to a “lactating” phenotype for a period of 7 days. 
Although there have been previous attempts to develop protein expression profiles for a 
“normal” mammary epithelial cell, few have considered the global changes that occur 
throughout the process of differentiation (Desrivieres, 2003). There are likely major 
differences, to be considered as well, between protein expression in human and murine 
MEC versus those of ruminant (specifically bovine) origin as there are major differences 
in metabolism, fat storage, and milk synthesis between the species (Van Soest, 1994). 
 
Proteomics is a discovery-based approach to molecular biology. By refraining from 
attempting to quantify expected genes or proteins, proteomics allow us to draw back the 
focus and identify total protein expression from a sample. From this point, we may 
compare across samples from different treatments or developmental stages to create new 
hypotheses for the molecular events taking place at the time of protein isolation. In this 
way, unexpected discoveries may be made that can later be expanded upon and validated 
through fine-tuned quantitative technologies. Transcriptomic technologies are highly 
valuable in that they provide a wider array of genes on which to base hypotheses, 
however, there is a high probability that many genes transcribed are never translated in 
vivo (Ou, 2008). While a combination of both assay types would amount to a more 
complex picture, the proteome depicts actual protein existence rather than relying on 
assumptions based upon presence of mRNA alone, which is why we selected this 
approach specifically. 
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In this study, total protein was extracted from MAC-T cells during cell proliferation or 
after seven days of differentiation, which should theoretically correspond with 
established lactation in vivo, as this was the treatment period in the former study upon 
which this experiment was based. Global protein expression was then visualized by two-
dimensional gel electrophoresis (2DGE) before identification of individual proteins that 
changed significantly in abundance through matrix assisted laser desorption/ionization- 
time of flight (MALDI-TOF/TOF) tandem mass spectrometry. 
 
45 
2.2 Methods 
 
All reagents were acquired from Sigma Aldrich (St. Louis, MO) unless otherwise noted. 
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2.2.1 Cell Culture 
 
MAC-T cells were cultured on 10 cm plastic plates under growth medium (low glucose 
Dulbecco’s Modified Eagle Medium with 10% FBS, 1% Penicillin/Streptomycin (PS), 
1% Amphotericin B, 5ug/mL insulin, 1ug/ml progesterone), which was replenished every 
48 hours until confluence at which point half of the plates were harvested for protein 
extraction. Differentiation was induced in the remaining plates with lactation media (low 
glucose Dulbecco’s Modified Eagle Medium with 10% FBS, 1% PS, 1% Amphotericin 
B, 1ug/mL dexamethasone, 5ug/mL insulin, 5ug/mL prolactin). Differentiated cells were 
cultured in lactation media replenished every 24 hours for an additional 7 days before 
harvest.  
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2.2.2 Protein Extraction 
 
Media was aspirated from all plates followed by a 1ml rinse of sterile filtered phosphate 
buffered saline solution (PBS). Cells from nine 10cm plates were pooled into three 
microfuge tubes (n=3, 3 plates per 2ml tube). Cells were rinsed again with PBS by vortex 
and centrifugation. Cells were lysed in 450ul lysis buffer (7M urea, 2M thiourea, 
1%ASB-14, 40mM tris base, 0.1% IPG buffer and 40mM DTT) followed by three 10-
second pulses of sonication with a probe sonicator while microfuge tubes remained on 
ice. Lysed cells were centrifuged at 4°C for 30 minutes at 10,400 x g. Supernatant 
containing protein extract was frozen at -80°C.  
 
Protein extracts were precipitated with a 10% TCA/acetone solution for 12 hours at -
20°C. Samples were rinsed with 100% acetone and allowed to dry before rehydration by 
working rehydration buffer (7M urea, 2M thiourea, 2% CHAPS, 2% Nonidet P-40, 
0.002% bromophenol blue, 0.05% immobilized pH gradient (IPG) buffer and 100mM 
DTE). Rehydration occurred over a 12 hour period at 4°C. Impurities were removed 
through centrifugation and rehydrated protein extracts were stored at -80°C. 
 
Protein concentrations were quantified using the 2D-Quant kit (GE Healthcare, Uppsala, 
Sweden).   
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2.2.3 Two-Dimensional Gel Electrophoresis (2D) 
 
An 11cm IPG strip (pH 3-10) was used to separate 200ug of protein from each sample 
through isoelectric focusing (Bio-Rad, Hercules, CA). IPG strips were actively 
rehydrated for 12 hours and separated by isoelectric focusing using the Bio-Rad Protean 
IEF cell preset 11cm rapid program (250V for 15 min, 8000V for 2.5 hours and 35000 
vhours). 
 
Proteins were separated in the second dimention, by molecular weight, on precast 
Criterion 10% tris-HCl 11cm gels using a Criterion Dodeca Cell (Bio-Rad, Hercules, CA) 
for 1 hour at 200V. All gels were run in duplicate. 
 
Proteins were stained overnight with colloidal Coomassie Blue G-250 (Coomassie Blue 
G-250, H2SO4, NaOH, glacial acetic acid and sterile water) and rinsed periodically with 
sterile water until protein spots were clearly visible. Stained gels were scanned and 
analyzed by Delta 2D gel image analysis software (DECODON, Germany). Spot 
volumes were analyzed using a t-test based on a null distribution that was generated using 
1000 permutations to account for unequal variance and non-normal distribution of the 
data.  Differences were considered significant at P < 0.01. 
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2.2.4 Tryptic Digestion and MALDI TOF/TOF Mass Spectrometry 
 
Protein spots were manually excised from 2D gels with a 1.5mm tissue arrayer puncher 
(Beecher Instruments, Sun Prairie, WI) and stored at -80°C in 0.5ml microfuge tubes. 
 
Coomassie blue was removed from the gel plugs by two 30-minute incubations on a 
shaking plate with destaining buffer (25mM NH4HCO3 and 50% acetonitrile).  
Destaining was followed by a wash with 100% acetonitrile and an overnight incubation at 
37°C in trypsin digestion solution (1ug/ul mass spectrometry grade porcine trypsin gold 
(Promega, Madison, WI) in 40 mM NH4HCO3 and 10% acetonitrile).  Digested peptides 
were eluted from gel plugs through two 30-minute incubations on a shaking plate with 
analyte solution (0.1%TFA and 33% acetonitrile). Supernatants were moved to new, 
0.5ml collection tubes after each incubation. Eluted peptides from each sample were 
dehydrated in a 45°C speedvac centrifuge for 50 minutes and rehydrated in a matrix 
solution (0.2mg/ml α-cyano-4-hydrocinnamic acid (HCCA) in acetonitrile). Each peptide 
sample was plated individually on an anchorchip target (Bruker Daltonics, Billerica, 
MA), washed with a rinse buffer (0.1% TFA in 10mM ammonium phosphate) and 
recrystallized with a solution of ethanol, acetone, and 0.1% TFA (6:3:1). Each sample 
was analyzed by ultraflex II MALDI-TOF/TOF mass spectrometry (Bruker Daltonics, 
Billerica, MA) and peptide mass fingerprints (PMF) were acquired and externally 
calibrated with FlexControl software (Bruker Daltonics, Billerica, MA). PMFs were 
further analyzed using MASCOT server launched from BioTools software (Bruker 
Daltonics, Billerica, MA) against the NCBI database. Carbamidomethylation and 
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oxidation were set as fixed modifications for MASCOT searches with a maximum of one 
missed cleavage. PMF were further analyzed using MS/MS spectra using five to ten of 
the largest peaks per sample (excluding keratin and trypsin). Spectra were internally 
calibrated and processed using FlexAnalysis software (Bruker Daltonics, Billerica, MA). 
PMF and MS/MS spectra were combined and queried as described for PMF spectra 
analysis using the MS/MS spectra. 
 
51 
2.2.5 Protein Analysis 
 
Estimated molecular weight and isoelectric point (pI) were calculated using ExPASy 
Bioinformatics Resource Portal software (www.expasy.org) and cellular localization, 
gene names and functions of proteins were acquired from the “UniProtKB” UniProt 
Protein Knowledgbase (UniProt Consortium, 2012) unless otherwise noted. 
 
 
52 
2.3 Results  
 
Through the use of Delta 2D, 223 individual protein spots were identified on the 
composite image of all gels. Of those 223, 82 spots (37%) differed in abundance between 
the two treatment groups (p < 0.01; see figure 3). Sixty-three spots were successfully 
matched to NCBI Blast database sequences and identified as listed in table 1. Of the 63 
proteins, 30 increased in abundance, or showed an up-regulation in the differentiated cells 
and 33 decreased in abundance, or were down regulated in the differentiated cells. 
 
In general the proteins identified to increase after differentiation were functionally related 
to cytoskeletal structure and dynamics, fatty acid synthesis, amino acid synthesis, protein 
synthesis and glycolysis. Down regulated proteins were generally related to calcium 
storage by the endoplasmic reticulum, mRNA processing in the nucleus, and the TCA 
cycle within the mitochondria. 
 
Table 1 represents differentially expressed proteins between proliferating 
(undifferentiated) MAC-T cells and differentiated MAC-T under DIP lactation media 
conditions for 7 days. Identified proteins range in molecular weight from approximately 
29 to 130 kDa, and in pI from 4 to 9. Proteins within the table are grouped based on 
functional category and sorted within the group by protein name, direction of regulation 
and fold change. Repetitions in protein names are associated with separate spots, which 
may be explained by post-translational modifications or other differences that lead the 
same protein to have either a different mass or pI.  
Figure 3. Fused Gel Image of MAC
 
Protein samples from proliferating and differentiated MAC
isoelectric point (horizontal axis) and molecular weight (vertical axis). Image represents a 
fusion of all 12 gels (n=3 per treatment, in duplicate). Spots that differed in abundance 
between treatments are circled and numbered. Numbers corres
table 1. 
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Figure 4. Heat Map of Significant MAC
 
Hierarchal clustering using Pearson’s correlation of MAC
significantly between pregnancy and lactation states. Blue represents abundances 
than the average for that particular spot, while orange represents greater than average 
protein abundance. The columns represent individual gels clustered by treatment/cell 
state. Rows represent individual protein spot
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Table 1. Identified proteins that differed in abundance between proliferating and 
differentiated MAC-T cells. “Regulation Direction” refers to change in protein spot 
abundance from proliferating to differentiated cell state, which is quantified by “Fold 
Change”. Fold change was calculated by dividing the mean spot abundance from 
differentiated cell gels by the mean abundance of the same spot from proliferating cell 
gels. 
 
Spot 
ID Protein Name 
Gene 
Name 
Regulation 
Direction 
Fold 
Change P-value 
MW 
(kDa) 
Predicted 
pI 
Predicted 
    
  
  
Cytoskeletal Microfilaments 
152 Actin, Beta Actb down 0.69 0.003 41679.72 5.29 
151 Keratin 13-like Krt13 up 3.62 <0.001 47183.24 4.86 
45 Keratin 6A Krt6A up 2.28 <0.001 60782.58 8.28 
102 Keratin, (type II) Cytoskeletal 
5 
Krt5 down 0.58 0.001 62449.11 6.90 
    
  
  
Cytoskeletal Dynamics 
220 (Predicted) Vinculin Isoform 
2 
Vin2 up 1.97 0.001 116642.35 5.83 
13 Ezrin Ezr up 1.87 <0.001 68717.49 6.06 
207 Gelsolin Isoform A Gsna up 2.93 0.003 85634.23 5.86 
125 LIM and SH3 Domain Protein 
1 
Lasp1 up 1.57 0.002 29658.13 6.61 
114 Macrophage Capping Protein Capg up 1.93 <0.001 38851.79 6.17 
98 Macrophage Capping Protein Capg up 1.60 0.001 38851.79 6.17 
24 Tripartite Motif-containing 29 Trim29 down 0.72 0.004 64931.20 6.70 
    
  
  
Calcium Trafficking/Storage 
124 Annexin A1 Anxa1 up 1.76 <0.001 38927.26 6.37 
209 BiP (78kD Glucose-Regulated 
Protein) 
Grp78 down 0.72 <0.001 62978.81 5.31 
133 Calreticulin Calr down 0.54 0.001 48067.88 4.33 
215 Endoplasmin Precursor Hsp90B1 down 0.53 <0.001 92369.23 4.76 
196 Protein disulfide isomerase P4hb down 0.55 <0.001 57167.77 4.80 
104 Protein Disulfide-isomerase 
A3 precursor 
Pdia3 down 0.55 0.001 56893.91 6.38 
    
  
  
Nuclear Proteins 
198 Heterogeneous Nuclear 
Ribonucleoprotein U-like 
Protein 2 
Hnrnpul2 down 0.50 <0.001 85139.05 4.84 
122 Poly(rC)- Binding Protein 2 Pcbp2 up 2.21 <0.001 36777.74 6.60 
90 Pre-mRNA-processing Factor 
19 
Prpf19 down 0.47 <0.001 55160.36 6.14 
31 Prelamin-A/C Lmna down 0.38 0.001 65082.57 6.54 
181 Prelamin-A/C Lmna down 0.58 0.001 65082.57 6.54 
182 Prelamin-A/C Lmna down 0.70 0.001 65082.57 6.54 
    
  
  
Pentose Phosphate Pathway 
119 6-Phosphogluconate 
Dehydrogenase, 
Decarboxylating  
Pgd up 3.45 
0.001 
53042.87 6.65 
    
  
  
Protein Synthesis  
187 Elongation Factor 2 Eef2 up 4.23 <0.001 95306.96 6.41 
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183 Elongation Factor 2 Eef2 up 2.41 <0.001 95306.96 6.41 
109 Elongation Factor Tu, 
mitochondrial precursor 
Eef2 up 1.55 0.005 49367.01 6.72 
14 Glycyl-tRNA Synthetase Gars up 1.92 <0.001 83064.51 6.94 
199 Hypoxia up-regulated protein 
1 
Hyou1 down 0.60 <0.001 111543.35 5.26 
135 Chaperonin (HSPD1 Protein) Hspd1 down 0.50 <0.001 42137.67 8.90 
    
  
  
Amino Acid Synthesis/Metabolism 
121 Argininosuccinate Synthase Ass1 up 1.71 <0.001 46387.85 7.15 
61 Argininosuccinate Synthase Ass1 up 1.35 0.006 46387.85 7.15 
38 Bifunctional Purine 
Biosynthesis Protein (PURH) 
Atic up 1.79 <0.001 64442.22 6.39 
166 GMP Synthase Gmps down 0.29 <0.001 77271.31 6.44 
50 Glutamate Dehydrogenase 1 Glud1 down 0.45 <0.001 57630.23 7.04 
53 Serine 
Hydroxymethyltransferase, 
mitochondrial precursor 
Shm1 down 0.47 
0.006 
55570.39 7.62 
117 Serine 
Hydroxymethyltransferase, 
mitochondrial precursor 
Shm1 down 0.70 
0.004 
55570.39 7.62 
    
  
  
Glycolysis 
127 Alpha-Enolase Eno1 up 3.26 <0.001 47254.35 6.37 
108 Alpha-Enolase Eno1 up 3.25 <0.001 47254.35 6.37 
95 Alpha-Enolase Eno1 up 2.06 <0.001 47254.35 6.37 
107 Alpha-Enolase Eno1 up 1.91 <0.001 47254.35 6.37 
71 Glyceraldehyde-3-Phosphate 
Dehydrogenase 
Gapdh up 2.36 0.001 35845.30 8.51 
69 Glyceraldehyde-3-Phosphate 
Dehydrogenase 
Gapdh up 1.51 0.005 35845.30 8.51 
39 Phosphoglucomutase-1 Pgm1 up 3.04 0.001 61550.75 6.36 
    
  
  
TCA Cycle/Mitochondrial Energy Metabolism 
48 Dihydrolipoyl 
Dehydrogenase, 
mitochondrial 
Dld down 0.52 
0.001 
54153.06 7.59 
169 Mitochondrial Aconitase 2 Aco2 down 0.60 0.002 78501.72 6.67 
28 Phosphoenolpyruvate 
Carboxykinase (GTP), 
mitochondrial 
Pck1 down 0.52 <0.001 70604.72 8.14 
179 Phosphoenolpyruvate 
Carboxykinase (GTP), 
mitochondrial 
Pck1 down 0.62 <0.001 70604.72 8.14 
115 Phosphoglycerate 
Dehydrogenase 
Phgdh up 1.51 0.004 56315.10 6.71 
140 Pyruvate Carboxylase Pc down 0.13 <0.001 129728.71 6.32 
141 Pyruvate Carboxylase Pc down 0.38 <0.001 129728.71 6.32 
168 Pyruvate Kinase Isozyme M2 Pkm2 up 1.81 <0.001 61388.73 8.62 
25 Succinate Dehydrogenase 
(complex subunit A) 
Sdha down 0.57 <0.001 60804.94 6.19 
    
  
  
Cell Signaling 
51 Adenylate cylase-assosiated 
protein 1 
Cap1 down 0.72 0.004 51169.38 7.16 
78 Guanine nucleotide-binding 
protein subunit beta-2-like 1 
Gnb2l1 down 0.66 0.001 35068.57 7.60 
185 Phosphlipase C-delta 1 Plcd1 up 1.80 <0.001 86019.27 6.27 
81 YWHAZ Protein (Homo YWHAZ up 3.43 0.009 35313.77 6.97 
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sapien) 
    
  
  
GTP Synthesis  
94 Rab GDP Dissociation 
Inhibitor Beta 
Gdi2 up 1.74 0.002 50455.67 5.93 
    
  
  
Cell Surface/Membrane Proteins 
224 (Predicted) Integrin Alpha-3 Itga3 down 0.33 <0.001 95515.79 6.35 
153 40S Ribosomal Protein SA Rpsa down 0.40 0.001 32876.44 4.80 
77 Voltage-Dependent Anion-
Selective Channel Protein 2 
Vdac2 down 0.49 0.001 31599.56 7.47 
    
  
  
Serum Protein 
218 Albumin (ALB) Alb down 0.34 0.003 69190.43 5.88 
217 Albumin (ALB) Alb down 0.35 0.002 69190.43 5.88 
 
 
*  Molecular weight (MW) and pI values estimated by ExPASy – Bioinformatics Resource Portal (www.expasy.org) 
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2.4 Discussion 
 
This study was designed to compare global protein expression in MAC-T cells before and 
after in vitro differentiation. Our interest in this transition within the MAC-T cell line 
arose due to results from an earlier experiment, which compared the proteomes of MAC-
T cells that had been differentiated in vitro and treated with or without exogenous growth 
hormone. Many of the proteins observed to change with GH treatment have known 
functions that may be associated with the transition to differentiation or establishment of 
lactogenesis in the mammary gland. The intent in designing the current study was to 
compare the stages of proliferation and differentiated MAC-T cells in order to then 
compare these results with those from the GH study. This discussion will address the 
changes in the proteome we observed in the current study and assess similarities between 
the current study and the GH treatment experiment previously conducted by Johnson et 
al. 
 
The majority of metabolic proteins that we observed to differ in abundance were related 
to the glycolytic pathway, TCA cycle and NADPH production, which is what we would 
expect from a bovine mammary epithelial cell preparing for lactose and fatty acid 
synthesis. We also observed changes in proteins related to cytoskeletal dynamics and 
RNA processing which was also expected due to the structural changes that must occur in 
order for lactation to proceed.  
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Calcium Storage/Trafficking Proteins 
Specifically related to the endoplasmic reticulum (ER), we observed down-regulation of 
ER resident proteins: calreticulin, endoplasmin (precursor), BiP (precursor; also known 
as 78kD glucose regulated protein) and two forms of protein disulfide-isomerase (P4hb 
and Pdia3). Calcium, commonly associated with the health benefits of milk is also 
necessary for a number of functions throughout the cytoplasm of all cells. Calcium is 
stored in the ER and must be transported throughout the cell via “chaperones” in order to 
perform its functions. While all of the ER proteins we detected have calcium binding 
capabilities, calreticulin has the highest capacity and with a phosphorylation site for 
casein kinase II may have a role in the secretion of calcium in milk (Rowling, 1994).  
 
The fact that we saw a decrease in abundance of these ER proteins after differentiation 
may illustrate a decreased need for the intracellular distribution of calcium for functional 
processes related to proliferation and perhaps a faster turnover between calcium influx 
and output through casein secretion. If this were the case, there may be a decrease in the 
need for ER storage and chaperoning of calcium by ER proteins. This hypothesis is 
supported by the up regulation of the protein annexin 1. Annexin 1 binds phospholipid, of 
which the cell membrane is made, but only when also bound to calcium, leading to a 
possible connection between annexin 1 and the exocytosis of secretory vesicles 
containing milk components (Creutz, 1992).  
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Metabolic Proteins 
In the ruminant mammary gland glucose availability is limited, and lactose synthesis is 
generally believed to be the first priority of glucose use. Consistent with this theory, we 
saw an up-regulation in phosphoglucomutase which is an enzyme involved in lactose 
synthesis. We also observed changes in other proteins related to glucose use including 
up-regulation of several glycolytic enzymes, including glyceraldehyde-3-phosphate 
dehydrogenase, alpha-enolase and phosphoglycerate dehydrogenase. The increase in 
abundance of these proteins indicates an increase in glucose breakdown to pyruvate, 
probably related to the increased energy demands during milk synthesis. However, the 
fate of the increased pyruvate stores that this pathway would generate is debatable.  
 
Within the mitochondrial TCA cycle, we observed a down-regulation in both 
dihydrolipoyl dehydrogenase and pyruvate carboxylase which are the two mitochondrial 
catalysts for reactions in which pyruvate is a substrate. Phosphenolpyruvate 
carboxykinase (PEPCK), which is the enzyme that can reversibly convert oxaloacetate to 
phosphoenolpyruvate (PEP), was also down regulated. However, pyruvate kinase was up 
regulated and this is the enzyme completing the final and irreversible transition of PEP to 
pyruvate. The changes in the above metabolic proteins appear to indicate a build up of 
pyruvate though glycolysis and conversion of PEP to pyruvate as well as an inhibition of 
the TCA cycle. Under aerobic conditions, if the fate of pyruvate is not the production of 
ATP through the TCA cycle, it may be participating in a transamination reaction in the 
presence of glutamate to produce both alpha-ketoglutarate and alanine. Alanine is a non-
essential amino acid (NEAA) that may be required to produce new proteins, and alpha-
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ketoglutarate can contribute to other pathways. For example, mitochondrial aconitase was 
down regulated, and this enzyme is responsible for another conversion within the TCA 
cycle involving the reversible transition of citrate to isocitrate. Alpha-ketoglutarate can 
also be converted to isocitrate in the mitochondria, and isocitrate can be shuttled out of 
the mitochondria to the cytosol and used as a precursor to NADPH production. If there is 
an abundance of isocitrate in the mitochondria as a result of transamination of pyruvate, it 
would reduce the need to convert citrate to isocitrate, sparing the energy that reaction 
would cost. NADPH is the required reducing agent for fatty acid synthesis, and the 
majority of it is most likely produced by this particular reaction in the ruminant due to 
absence of citrate lyase activity and limited availability of glucose for the pentose 
phosphate pathway. Even though it is most likely secondary to isocitrate dehydrogenase 
production, the pentose phosphate pathway remains a source of NADPH production, and 
this is supported by our data through the observed increase in abundance of 6-
phosphogluconate dehydrogenase (for reference, see figures 1 and 2 in chapter 1). 
 
Cytoskeletal Proteins and Cytoskeletal Dynamics-related Proteins 
As epithelial cells differentiate they change in structure, shape and motility and changes 
in cytoskeletal proteins related to these transformations were to be expected. The cellular 
cytoskeleton is made up of microfilaments assembled from actins, intermediate filaments 
and microtubules. Among cytoskeletal proteins detected to change, we saw an up 
regulation in keratins 6a and 13, which are both typical intermediate filaments in 
epithelial cells. Specifically keratin 6a is expressed only in luminal epithelial cells and 
cells of terminal end buds within the mammary ductal system, a fact that supports our 
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selection of MAC-T as a model for this cell type (Bu, 2011). Additionally, we observed a 
down regulation of keratin 5, and this is a filament expressed during the differentiation of 
epithelial cells and is perhaps no longer necessary to a fully differentiated, lactating 
phenotype.  
 
Beta-actin was the only actin sub-unit in which we detected a change and it was down 
regulated. This does not necessarily contradict the up regulation of keratins because re-
organization is bound to change demands for different building materials in the 
cytoskeleton. Specifically, actin is often associated with cell motility, an important 
characteristic for epithelial cells during proliferation in order to populate a mammary 
gland (Mayanagi, 2011). However, once the functional epithelium is established and 
differentiated to a lactating phenotype, motility is no longer necessary and would likely 
hinder milk secretion. Complementary to this analysis, we saw up regulation of proteins 
related to cytoskeletal dynamics and actin re-organization such as gelsolin-a, LIM and 
SH3 domain protein 1 and macrophage capping protein, which indicate a change in cell 
structure that may have altered the activity of actin post-translation. LIM and SH3 
domain protein 1 has been identified in other secretory epithelial cell types as well, and is 
thought to be involved in linking intracellular signaling pathways, including, but not 
limited to, regulating actin-related ion transport (Chew, 2000). 
 
Gelsolin is an actin-capping and severing protein, meaning it binds to actin filaments to 
prevent the exchange of monomers with the unique ability to both assemble or sever 
formed filaments. Gelsolin is decreased in breast tumors, and up-regulate in response to 
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anti-growth medication indicating a preventative effect on motility and proliferation 
(Brackley, 2011). Macrophage capping protein is alternately known as “gelsolin-like 
capping protein” and shares many characteristics with gelsolin in relation to actin-based 
cell motility although it was originally isolated from alveolar macropahges (Zhu, 2011). 
Interestingly, macrophage capping protein was also up-regulated in response to GH 
treatment in the previously conducted MAC-T experiment. 
 
In relation to cytoskeletal dynamics, we saw an increase in the abundance of proteins 
viniculin 2 and ezrin which both function as intermediates connecting the plasma 
membrane of the cell to the cytoskeleton. Viniculin binds actin filaments and is involved 
in cell-to-cell and cell matrix adhesion (Coll, 1995). Ezrin has been associated 
specifically with the apical membrane and the maintenance of polarity in epithelial cells. 
Adhesion for signaling and established polarity are essential characteristics for lactation 
in the epithelium (Saotome, 2004). 
 
Lamin A/C are also cytoskeletal proteins, but are more closely related to the nucleus. 
These intermediate filament proteins, present in all mammals, comprise the inner most 
layer of the nuclear membrane termed nuclear lamina. Recently, it has been proposed that 
lamins are not only structural in nature, but also interact with chromatin affecting gene 
regulation (Puckelwartz, 2011). Lamin-associated domains have been identified which 
allow chromatin to interact directly with the nuclear lamin, causing a change in 
transcription, which is most often a repressive effect (Puckelwartz, 2011). If 
differentiation does in fact reduce the abundance of nuclear lamins, and therefore reduces 
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the interaction between lamins and repressive lamin-associated domains, this effect may 
contribute to a change in genes being transcribed for the new, functional cell state. 
 
Proteins of Particular Interest 
One unexpected change was observed in YWHAZ protein, one of the most significantly 
up-regulated proteins observed. YWHAZ is known to be involved in the regulation of a 
spectrum of general cell signaling pathways. Its increase of greater than 3 fold between 
states of differentiation is interesting due to the fact that the gene for this protein has been 
previously been deemed appropriate as a “housekeeper” or reference gene for PCR 
studies in 33 bovine tissues including the mammary gland (Lecchi, 2012). This provides 
an excellent example of discrepancy between mRNA and protein abundance. While it 
may be a good reference gene on the transcript level, the abundance of this protein may 
not be dictated by the abundance of mRNA. 
 
Another unexpected result was the up-regulation of argininosuccinate synthase, which we 
observed in differentiated MAC-T. Argininosuccinate synthase is an enzyme generally 
associated with the urea cycle that is not typically associated with the mammary gland. In 
fact until very recently, this enzyme has been linked exclusively to the liver. In a review 
published in 2011, it was noted that argininosuccinate synthase plays a role not only in 
the urea cycle, but also in several other pathways including de novo arginine synthesis 
(Haines, 2011).  Arginine is often considered a “semi-essential” amino acid, due to the 
fact that most adult animals produce enough arginine in the kidneys to balance dietary 
sources, reaching the required metabolic demand (Haines, 2011). In the neonate however, 
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enterocytes also express argininosuccinate synthase perhaps due to the fact that milk is 
relatively low in arginine when compared to the needs of growing young. The uptake of 
arginine from the plasma by the lactating mammary gland of the sow has been 
demonstrated to be significantly lower than the output of arginine in milk, indicating a 
demand for arginine in the process of lactation (O’Quinn, 2002). It is feasible then, that 
de novo arginine synthesis is occurring within the lactating MEC in order to meet this 
demand. Specific fates of this amino acid warrant further investigation.  
 
Relationship with Growth Hormone Experiment 
In the previously conducted study comparing differentiated MAC-T cells treated with and 
without GH, analysis suggested a possible parallel between the transition of 
differentiation and the direct effect of GH on the mammary epithelial cell. When 
comparing results from the two experiments, there is a great deal of overlap in the 
functional groups of proteins that changed in abundance, and several of the same proteins 
changed in the same direction of regulation. Notably, the up regulation observed in 
pathways promoting and increase in NADPH production are similar to those seen with 
GH treatment. As discussed, NADPH is an important factor in fatty acid synthesis, which 
is essential to milk production, especially in the ruminant. Also similar was the increase 
in glycolytic enzyme, alpha-enolase, which facilitates the last step in glycolysis resulting 
in the production of phosphoenolpyruvate from 2-phosphoglycerate. This increase may 
indicate an increase in the use of glycerol from TAG for the synthesis of pyruvate, which, 
as previously discussed, may be contributing to NEAA synthesis through transamination. 
By taking advantage of glycerol in this manner, glucose may be spared for lactose 
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synthesis without detriment to the TCA cycle and associated pathways in the ruminant 
cell.  
 
Additionally, there were similarities in the changes of cytoskeletal proteins indicating a 
similar re-organization of the cell structure due to functional differentiation of the cell 
and treatment with GH. The hypothesis postulating an overlap between the effect of GH 
and the changes that occur between the proliferation of mammary epithelium and the 
stage of functional differentiation is supported in part by these similarities, providing 
additional evidence that the effect of GH on the mammary epithelium may be to 
potentiate the process of differentiation. Future experiments could be designed based on 
this hypothesis with more specificity to individual genes, proteins and pathways. A time 
course experiment would also be beneficial to observe how changes occur through the 
process of differentiation as opposed to just looking at singular time-points before and 
after this functional shift in the mammary epithelium. 
 
As we have demonstrated, immortalized cell lines are excellent sources upon which 
hypotheses may be based. These cells are homogenous, easy to obtain and undergo 
structural and functional changes in vitro that qualify as induced differentiation. 
However, it is important to consider the probable effects of human intervention and the 
unnatural, in vitro environment. The following chapter will describe an experiment 
designed to compare what we observed in the MAC-T cell line with primary cells 
isolated before and after in vivo differentiation, in order to test and improve our 
hypotheses.  
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CHAPTER 3 – A proteomic analysis of differentiation, in vivo through the comparison 
primary mammary epithelial cells from pregnant and lactating mice 
 
3.1 Introduction 
 
Although rudimentary development of the mammary gland begins during fetal 
development and puberty, a mammary gland does not fulfill its functional potential until 
the female has undergone a full-term pregnancy and parturition (Gjorevski, 2011). The 
mammary gland undergoes major development during pregnancy, characterized by the 
tertiary side-branching of the ductal structure and the exponential proliferation of 
epithelial cells, some of which will undergo a final differentiation to become secretory, 
milk-producing cells (Brisken, 2006). In the context of protein biosynthesis, this 
transition begins with the up-regulation of enzymes involved in the synthesis of milk 
components, specifically lactose, caseins, and whey proteins alpha-lactalbumin and beta-
lactoglobulin. Although the hormonal signals prompting this switch in cellular function 
of the mammary epithelium have long been understood, the molecular events within the 
epithelial cell, which physically establish the new phenotype, are still somewhat unclear 
(Gjorevski, 2011).  
 
In this study, primary mammary epithelial cells (pMEC) were isolated from whole 
mammary glands of ICR mice at mid-pregnancy or peak lactation. Total protein was 
extracted from each cell type and global protein expression was visualized by two-
dimensional gel electrophoresis (2DE) before identification of individual proteins that 
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changed significantly in abundance through MALDI-TOF/TOF mass spectrometry for 
analysis. 
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3.2 Methods 
 
All reagents were purchased from Sigma Aldrich (St. Louis, MO) unless otherwise noted. 
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3.2.1 Animals 
 
ICR mice were purchased from Taconic Farms, Inc. (Oxnard, CA). All protocols were 
designed in accordance with the PHS Policy for Humane Care and use of Laboratory 
Animals and approved by the California Polytechnic State University Institutional 
Animal Care and Use Committee. 
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3.2.2 Primary Cell Isolation 
 
Fat pads were excised from 7-10 week-old ICR outbred mice at either day 10 of 
pregnancy or day 10 of lactation and rinsed in 1X Hank’s Balanced Salt Solution 
(HBSS). Tissue was manually minced to fragments of approximately 3mm3 and digested 
in a collagenase, trypsin, EDTA and Dulbecco’s Modified Eagle’s Medium (DMEM) 
cocktail during a 90-minute shaking incubation at 37°C. The cell pellet was sequentially 
re-suspended and incubated in red blood cell (RBC) lysis buffer (Millipore, MA), EDTA 
and DNase solutions before filtration through a 100um filter. As fibroblasts (a 
contaminating cell type) adhere very quickly to plastic, they were removed through a 
one-hour incubation on a T-182 flask. Epithelial cells that remained in suspension after 
one hour were removed, centrifuged and re-suspended in a 1x DMSO cell freezing 
medium and brought to -80°C over night. Frozen vials were stored in liquid nitrogen until 
the date of protein extraction. 
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3.2.3 Protein Isolation, 2DE, Tryptic Digestion and MALDI TOF/TOF Mass 
Spectrometry and Data Analysis 
 
All protein samples were isolated, treated and analyzed as described in chapter 2, sections 
2.2.2-2.2.5. 
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3.2.4 Flow Cytometry 
 
Viability of primary cells was determined through the use of ViaCount (Guava/Millipore) 
and its associated computer application in conjunction with a Millipore flow cytometer. 
Cell pellets from each vial were collected by centrifugation at 400 x g for 5 minutes. Cell 
freezing media was removed and pellets were rinsed in phosphate buffered saline solution 
(PBS) twice. Two aliquots of each cell type were taken at this point for cell viability 
estimation. Trypan blue (Thermo Scientific, South Logan, UT) was added to the first 
aliquot of each cell type for visual examination of viability on a hemocytometer (Hausser 
Scientific, Horsham, PA). This visual estimation was compared with flow cytometry after 
the second aliquot was incubated with ViaCount solution according to the product 
literature and suggested protocols. 
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3.3 Results 
 
Flow cytometry determined cells isolated from pregnant mice to be 40% viable and cells 
from lactating mice to be 41% viable immediately after thaw from liquid nitrogen. 
Unfortunately, our efforts to validate the epithelial origin of the primary cells were 
inconclusive (please see appendix). 
 
Through the use of Delta2D, 125 spots on the composite image of all gels were identified 
to be significantly different between the two treatment groups (p < 0.01). A total of 92 
spots were successfully matched to NCBI Blast database sequences to be identified as 
specific proteins listed in table 2.  Of the 92 proteins identified to change, 45 proteins 
were up regulated and 47 were down regulated in mammary epithelial cells from 
lactating mice compared to pregnant. Overall, 18 proteins matched proteins listed in table 
1 in the previous chapter, although the direction of regulation was the same for only 7 of 
those 18; the remaining similar proteins were regulated in the opposite direction. 
Although this overlap in specific proteins may seem insubstantial, the functional groups 
into which changing proteins were divided show great similarity. 
 
In general, the proteins that increased in abundance from pregnancy to lactation were 
functionally related to fatty acid synthesis, amino acid catabolism, tricarboxylic acid 
cycle and electron transport chain, and secreted proteins. The down-regulated proteins 
were generally related to cytoskeletal structure and dynamics, protein synthesis, mRNA 
processing and transcription, and molecular chaperoning.  
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Table 2 represents differentially expressed proteins between proliferating cells isolated 
from the developing mammary gland of a mid-pregnant ICR mouse and differentiated 
cells isolated from a lactating ICR mouse. Identified proteins range in molecular weight 
from approximately 23 to 272 kDa, and in pI from 4 to 11. Proteins within the table are 
grouped based on functional category and sorted within the group by protein name, 
direction of regulation and fold change. Repetitions in protein names are associated with 
separate spots, which may be explained by post-translational modifications or other 
differences that lead the same protein to have either a different mass or pI.  
Figure 5. Fused Gel Image of Primary Murine Mammary Epithelial Cell Protein Spots
 
Protein samples from the mammary epithelial cells isolated from pregnant and lactating 
mice were separated by isoelectric 
axis). Image represents a fusion
differed in abundance bet
ID” in table 2. 
 
 
 
76 
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Figure 6. Heat Map of Significant Prim
Murine Mammary Epithelial Cell Proteins
 
 
Hierarchal clustering using Pearson’s 
correlation of murine mammary epithelial 
cell protein spots that changed significantly 
between pregnancy and lactation states. Blue 
represents abundances lower than the 
average for that particular spot, while orange 
represents greater than average protein 
abundance. The columns represent 
individual gels clustered by treatment/cell 
state. Rows represent individual protein 
spots. 
 
 
ary 
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Table 2. Identified proteins that differed in abundance between mammary epithelial cells 
isolated from pregnant and lactating mice. “Regulation Direction” refers to the change in 
protein spot abundance from pregnant to lactating cell stages, which is quantified by 
“Fold Change”. Fold change was calculated by dividing the mean spot abundance from 
lactating mouse gels by the mean abundance of the same spot from pregnant mouse gels. 
 
 
Spot 
ID Protein Name 
Gene   
Name 
Regulation 
Direction 
Fold 
Change 
P-
value 
MW (Da) 
Predicted  
pI 
Predicted 
        
Cytoskeletal Microfilaments 
97 Keratin 18 Krt18 down 0.41 0.003 47460.24 5.3 
57 Keratin 5 Krt5 up 2.34 <0.001 61742.60 7.6 
136 Keratin 8 Krt8 down 0.34 <0.001 54531.46 5.7 
123 Keratin 8 Krt8 down 0.45 0.002 54513.50 5.7 
124 Keratin 8 Krt8 down 0.53 0.006 54531.46 5.7 
72 Vimentin Vim down 0.40 0.003 51533.09 5.0 
        
Cytoskeletal Dynamics 
64 Elfin Pdlim1 down 0.29 0.006 35751.89 6.4 
63 LIM and SH3 Domain 
Protein 1 
LASP1 down 0.29 0.003 29975.31 6.6 
67 Macrophage Capping 
Protein, isoform 2 
CAPG down 0.25 0.002 38744.68 6.5 
117 Protein Disulfide-Isomerase 
(precursor) 
P4hb up 2.80 <0.001 57022.77 4.8 
        
NADPH Production 
18 Isocitrate Dehydrogenase, 
cytoplasmic 
Idh1 down 0.40 0.002 46644.47 6.7 
81 Pyrroline-5-carboxylate 
reductase 2 
Pycr2 up 1.95 0.002 33637.62 7.7 
4 Transketolase Tkt down 0.54 0.001 67587.58 7.2 
        
Fatty Acid Synthesis 
21 Acyl-coenzyme A 
Dehydrogenase, medium 
chain 
Acadm up 2.01 <0.001 46407.57 8.6 
87 Fatty Acid Synthase Fasn up 5.46 <0.001 272256.77 6.1 
33 Monoglyceride Lipase 
(isoform a) 
Mgll up 3.45 <0.001 35233.96 7.2 
        
Protein Synthesis 
144 Elongation Factor 2 Eef2 down 0.46 0.005 95252.89 6.4 
143 Elongation Factor 2 Eef2 down 0.50 0.009 95252.89 6.4 
91 Elongation Factor 2 Eef2 down 0.58 <0.001 95252.89 6.4 
127 Serine, tRNA ligase Sars down 0.43 <0.001 58720.97 6.2 
        
Amino Acid Metabolism 
111 Bifunctional Purine 
Biosynthesis Protein 
(PURH) 
Atic down 0.33 <0.001 64177.42 6.5 
7 Inosine-5'-monophosphate 
Dehydrogenase 2 
Impdh2 up 1.87 <0.001 55779.77 6.3 
65 Serine 
Hydroxymethyltransferase 
Shmt2 down 0.36 <0.001 52551.50 6.5 
79 
86 3-hydroxyisobutyrate 
dehydrogenase, 
mitochondrial precursor 
Hibadh up 1.51 0.006 35416.60 8.4 
82 Acetyl-CoA 
acetyltransferase, 
mitochondrial 
Acat1 up 1.45 0.005 44787.34 8.7 
        
Glycolysis 
60 Alpha-Enolase Eno1 down 0.58 0.004 47098.24 6.2 
        
Mitchondrial Matrix/TCA Cycle 
96 Aconitase 2, mitochondrial Aco2 up 2.30 <0.001 85444.00 8.1 
36 Aconitase 2, mitochondrial Aco2 up 1.59 0.01 85444.00 8.1 
37 Aconitase 2, mitochondrial Aco2 up 1.42 0.002 85444.00 8.1 
8 Aldehyde Dehydrogenase  Aldh2 up 2.02 0.002 57924.49 8.3 
109 Aldehyde Dehydrogenase Aldh4a1 up 2.02 <0.001 39448.25 7.8 
145 Alpha-ketoglutarate 
Dehydrogenase 
Ogdh down 0.30 0.005 117683.21 6.5 
41 Citrate Synthase, 
mitochondrial precursor 
CS up 6.13 <0.001 51703.38 8.7 
42 Citrate Synthase, 
mitochondrial precursor 
Cs up 3.48 <0.001 51703.38 8.7 
40 Citrate Synthase, 
mitochondrial precursor 
Cs up 2.37 0.001 51703.38 8.7 
19 Citrate Synthase, 
mitochondrial precursor 
Cs up 1.84 <0.001 51703.38 8.7 
12 Glutamate Dehydrogenase 1, 
mitochondrial 
Glud1 up 1.43 0.004 61298.17 8.1 
110 Phosphoenolpyruvate 
Carboxykinase 2, 
mitochondrial 
Pck2 down 0.35 <0.001 70448.40 6.9 
140 Pyruvate Carboxylase, 
mitochondrial 
Pc up 5.10 <0.001 129602.46 6.3 
139 Pyruvate Carboxylase, 
mitochondrial 
Pc up 3.78 0.001 129749.50 6.3 
20 Pyruvate Dehydrogenase E1 
(subunit alpha), 
mitochondrial 
Pdha1 up 1.98 <0.001 43203.63 8.5 
103 Pyruvate Dehydrogenase E1 
(subunit beta), mitochondrial 
PDHB up 5.99 <0.001 34813.76 5.6 
121 Pyruvate Dehydrogenase E2 Dlat up 2.22 <0.001 67898.68 8.8 
9 Succinyl-CoA: 3-ketoacid-
coenzyme A transferase 1, 
mitochondrial precursor 
Oxct1 up 2.30 <0.001 55953.00 8.7 
13 Succinyl-CoA: 3-ketoacid-
coenzyme A transferase 1, 
mitochondrial precursor 
Oxct1 up 2.22 <0.001 55953.00 8.7 
        
Inner Mitochondrial Membrane/Electron Transport Chain 
58 Electron Transfer 
Flavoprotein (subunit beta) 
Etfb up 2.16 <0.001 27605.98 8.3 
32 Electron Transferring 
Flavoprotein, alpha 
polypeptide 
Etfa up 2.12 <0.001 35017.51 8.6 
105 Methylcrotonyl-coenzyme A 
Carboxyl (alpha) 
Mcca down 0.42 <0.001 79265.35 7.7 
50 Succinate Dehydrogenase 
Flavoprotein (subunit a), 
mitochondrial precursor 
Sdha down 0.53 <0.001 72539.17 7.1 
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48 ATP Synthase (subunit 
alpha), mitochondrial  
Atp5a1 up 2.81 0.002 59715.59 9.2 
39 ATP Synthase (subunit 
alpha), mitochondrial  
Atp5a1 up 1.48 <0.001 59715.59 9.2 
        
Nuclear Proteins 
30 Arginine/Serine-rich 
Splicing Factor 1 
Srsf1 down 0.35 <0.001 24421.16 10.1 
59 Arginine/Serine-rich 
Splicing Factor 2 
Srsf2 down 0.38 <0.001 25461.18 11.9 
101 Nucleophosmin 1 Npm1 down 0.25 <0.001 32567.84 4.6 
54 Pre-mRNA Processing 
Factor 19 (isoform 2) 
Prpf19 down 0.60 0.009 55204.39 6.1 
105 Prelamin A/C Lmna down 0.42 <0.001 65406.68 6.4 
56 Prelamin A/C Lmna down 0.52 0.008 65406.68 6.4 
66 Proliferation Associated 
Protein 2G4 
Pa2g4 down 0.38 0.002 43671.21 6.4 
        
Transcription Factors 
3 Far-upstream Element 
Binding Protein 1 
Fubp1 down 0.35 0.004 44933.88 9.0 
94 Far-upstream Element 
Binding Protein 2 
Fubp2 down 0.64 0.001 79348.69 9.0 
75 KappaB Motif binding 
phosphoprotein 
Hivep3 down 0.27 <0.001 51010.40 5.2 
76 KappaB Motif binding 
phosphoprotein 
Hivep3 down 0.35 0.002 51010.40 5.2 
61 TAR DNA-binding Protein 
43 (isoform 1) 
Tdp43 down 0.61 <0.001 44519.29 6.3 
        
mRNA Processing/Transport 
83 Heterogenous Nuclear 
Ribonucleoprotein A3 
Hnrnpa3 down 0.18 0.001 37063.20 8.5 
79 Heterogenous Nuclear 
Ribonucleoprotein A3-like 
Hnrnpa3 down 0.15 <0.001 23529.62 7.1 
135 Heterogenous Nuclear 
Ribonucleoprotein H 
Hnrnph1 down 0.40 <0.001 49168.40 5.9 
80 Heterogenous Nuclear 
Ribonucleoproteins A2/B1 
Hnrnpa2b1 down 0.28 0.001 32440.44 8.7 
100 Heterogenous Nuclear 
Ribonucleoproteins C1/C2 
Hnrpc down 0.12 <0.001 34363.86 4.9 
99 Heterogenous Nuclear 
Ribonucleoproteins C1/C2 
Hnrpc down 0.21 <0.001 34363.86 4.9 
98 Heterogenous Nuclear 
Ribonucleoproteins C1/C2 
Hnrpc down 0.40 0.002 34363.86 4.9 
        
Cell Signaling 
118 TNF Receptor-Associated 
Protein 1 
Traf1 up 1.61 0.002 81155.13 6.4 
GTP Synthesis 
34 G-protein (beta subunit-like) Gnb1 up 1.56 <0.001 34996.55 8.1 
        
Molecular Chaperones 
47 T-complex Protein 1 
(subunit beta) 
Cct2 down 0.33 <0.001 59614.11 8.0 
69 Valosin-Containing Protein Nvl down 0.41 0.002 89251.70 5.1 
70 Valosin-Containing Protein Nvl down 0.48 <0.001 89251.70 5.1 
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Homeostatic Maintenance 
35 Carbonic Anhydrase 2 Ca2 down 0.10 <0.001 29014.50 6.5 
90 Mercaptopyruvate 
Sulfurtransferase 
Mpst up 1.58 <0.001 33018.53 6.1 
27 Sialic Acid Synthase Nans down 0.39 0.002 39998.36 6.6 
        
Membrane Proteins 
49 EH-domain Containing 4 Ehd4 down 0.48 0.002 61453.32 6.1 
78 Voltage-Dependent Anion-
Selective Channel Protein 2 
Vdac2 up 1.61 <0.001 31712.58 7.4 
        
Secreted Proteins 
102 Alpha-s1 Casein Csn1 up 4.05 0.001 34775.43 6.3 
1 Hemiferrin, Transferrin-like 
Protein 
LOC286987 up 1.64 <0.001 24075.49 7.9 
130 Serotransferrin precursor 
(bos taurus) 
TF up 4.54 <0.001 77615.72 7.1 
95 Transferrin Trf down 0.64 <0.001 76627.67 6.9 
114 Transferrin Trf up 6.72 <0.001 76627.67 6.9 
115 Transferrin Trf up 6.21 <0.001 76627.67 6.9 
2 Transferrin Trf up 3.08 <0.001 76627.67 6.9 
128 Transferrin Trf up 3.06 0.003 76627.67 6.9 
116 Transferrin Trf up 2.91 <0.001 76627.67 6.9 
        
Serum Protein 
120 Albumin Alb up 3.46 0.001 68647.71 5.8 
119 Albumin Alb up 2.82 <0.001 68264.81 5.9 
        
Unknown Function 
84 ES1 Protein homolog, 
mitochondrial precursor 
D10Jhu81e up 3.14 0.007 28072.78 9.0 
 
*values estimated by ExPASy – Bioinformatics Resource Portal (www.expasy.org) 
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3.4 Discussion 
 
In this chapter, we have presented a comparison of proteomic expression by the 
mammary epithelial cell during mid-pregnancy and peak lactation in the ICR mouse. The 
total gestation period for this breed of mouse is approximately 19 days. Day 10 of 
pregnancy was selected as the first day of cell isolation due not only to it being a half-
way-point in gestation, but also due to previous studies showing day 10 as a point at 
which proliferation of the epithelium was still occurring yet alveoli had not yet begun to 
develop (Brisken, 2006). Day thirteen of lactation has been demonstrated to be the point 
of “peak lactation” in former mouse studies, so we selected day 10 post-parturition as our 
second isolation point, assuming the mammary gland would be fully differentiated to a 
lactating state and not yet transitioning into apoptosis or regression (Brisken, 2006).   
 
Because our focus in this study is specific to the mammary epithelium, it was necessary 
to isolate only this cell type from the surrounding mammary gland. While plating and 
culturing the primary cells would have benefitted our sample volume and reduced 
contamination of dead cells and debris, our goal was to measure the proteins being 
expressed at these specific stages in vivo, and so we chose not to plate or culture the cells 
prior to protein extraction. The mammary epithelial layer, as it exists within the 
mammary gland, is spherical within alveoli and tight junctions are formed between cells. 
In order for individually isolated primary cells to attach to a flat, plastic surface such as a 
culture dish, it is very likely they must undergo significant proteomic changes to adapt to 
that new environment. Furthermore, if cells isolated from an animal during established 
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lactation are encouraged to revert to a proliferative state in vitro, they cannot be assumed 
to express a proteome representative of a lactating mammary gland. A change in 
translation occurs over many hours and we cryogenically froze primary cells immediately 
after isolation. We decided that extracting protein samples from cells immediately post-
thaw would then be the best strategy for obtaining the most accurate representation of in 
vivo proteomic expression in the mammary epithelium. 
 
As attempts to successfully validate the epithelial nature of our primary cells were 
unsuccessful, it is necessary to discuss the possible contaminating cell types in the sample 
population. The mammary epithelium exists within a fat pad in the mouse, which 
contains a great deal of adipose tissue and stroma. Adjacent to the epithelium are 
myoepithelial cells, the extracellular matrix, made up of fibroblasts, and blood vessels. 
Due to the extremely adherent properties of fibroblasts, they are likely removed from the 
epithelial population though a one-hour incubation period on a plastic surface during the 
cell isolation procedure. Adipose cells are removed through centrifugation, as this cell 
type is less massive than others and forms a layer above liquids used during the cell 
isolation procedure. Other stroma and blood should be absent from the sample due to 
collagenase and red blood cell lysis buffers also employed during the primary cell 
isolation process.  
 
The majority of differences in global protein expression in mammary epithelial cells 
isolated from pregnant and lactating mice appear to be related to metabolism, structure 
and RNA processing. These proteins, and probably many that went undetected, must 
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change in order to cease proliferation, re-structure and equip the cell with all necessary 
elements for the effective synthesis and secretion of milk components. While our lists of 
differently regulated proteins are broad and individual proteins may be associated with 
multiple roles or cell processes, this global expression data set will serve as a starting 
point for future validation experiments with more specific hypotheses.  
 
Metabolic Proteins 
One group of metabolic proteins identified to change is related to the products of 
glycolysis, the pentose phosphate shunt and TCA cycle. The pentose phosphate shunt is a 
known driver of fatty acid production in the mammary epithelium, as NADPH is 
produced providing the reducing equivalent for fatty acid synthase function (Salway, 
1994). Interestingly, we observed a down regulation of transketolase in the lactating 
mouse MEC, indicating a possible reduction in the use of the pentose phosphate pathway 
even though we saw an increase in the abundance of fatty acid synthase. In the rodent, 
NADPH can also be derived from the conversion of malate to pyruvate, termed the 
malate transhydrogenation cycle, and the cleavage of isocitrate into alpha-ketoglutarate 
within the cytosol. Additionally, we saw an upregulation on pyrroline-5-carboxylate 
reductase 2, the action of which has also been shown to be a source of NADPH 
production in the rat liver (Hagedorn, 1986).  It is possible that the necessary increase in 
fatty acid synthesis is being driven by the product of those reactions, while glucose is 
being shunted towards lactose synthesis, glycolysis, and mitochondrial TCA cycle, rather 
than the pentose phosphate pathway.  
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Again, we saw a number of pyruvate-associated proteins change. One of which, 
mercaptopyruvate sulfurtransferase, is an enzyme involved in cellular detoxification and 
is known to be inhibited by alpha-keto acids, pyruvate and alpha-ketoglutarate. In this 
experiment, we observed an up-regulation of the enzyme, which could possibly be the 
response of lactating epithelium to the buildup of pyruvate and alpha-ketoglutarate.  
 
Within the mitochondrial protein changes, we observed an upregulation of aldehyde 
dehydrogenase and beta-hydroxy-butyrate dehydrogenase, which are associated with the 
breakdown of acetate and beta-hydroxy butyrate to provide additional sources of acetyl 
CoA, a substrate for the TCA cycle and subsequent ATP synthesis. Complementary to an 
increase in acetyl CoA were the increases observed in pyruvate dehydrogenase, which is 
the enzyme responsible for oxidation of pyruvate (the final product of glycolysis) into 
acetyl CoA, and pyruvate carboxylase, which catalyzes the carboxylation of pyruvate to 
oxaloacetate.  Both oxaloacetate and acetyl CoA are necessary for the TCA cycle to 
progress, producing citrate from the condensation of the two substrates catalyzed by 
citrate synthase, an enzyme in which we also saw an upregulation. On a related note, the 
aldehyde dehydrogenase family of proteins have been noted as markers of stem cells 
within the human breast, and ALH2 specifically, one of the enzymes in which we 
detected an up-regulation upon differentiation, has also been noted to change upon 
differentiation in other cell types (Moreb, 2008). The aldehyde dehydrogenase family 4 
member A1 protein is involved in the process of interconnecting the TCA cycle and urea 
cycle (The UniProt Consortium, 2012). Although there is no known urea cycle activity in 
the mammary epithelium, the up regulation of this enzyme is curious, as we saw another 
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unexpected urea cycle-associated enzyme change in abundance in the MAC-T cell 
differentiation experiment. This occurrence would make an interesting point for further 
investigation. 
 
The next reaction occurring in the TCA cycle is the reversible dehydration of citrate into 
isocitrate catalyzed by aconitase. We did observe an increase in the abundance of 
aconitase as well, which is interesting because both citrate and isocitrate may be shuttled 
from the mitochondria to participate in other metabolic pathways however, cytosolic 
citrate may be cleaved into oxaloacetate and acetyl CoA by the enzyme citrate lyase 
while isocitrate is restricted to the fate of becoming alpha-ketoglutarate through isocitrate 
dehydrogenase activity. Cytosolic isocytrate dehydrogenase abundance was down 
regulated in the cells isolated from lactating mice along with the mitochondrial enzymes 
alphaketoglutarate dehydrogenase, succinate dehydrogenase, serine hydroxy-methyl 
transferase and phosphenolpyruvate carboxykinase (PEPCK). These enzymes, excluding 
PEPCK, are associated with the TCA cycle and all catalyze steps following the 
production of alpha-ketoglutarate. The combination of all of these changes indicate a 
build up of citrate and isocitrate within the mitochondria, and due to the reversibility of 
aconitase activity, both products may be shuttled out of the mitchondria, dependent on 
metabolic demands.  In this way, citrate is likely contributing to fatty acid synthesis in a 
way that is not possible in the ruminant mammary epithelial cell. Not only does citrate 
produce acetyl CoA as a precursor for fatty acid synthesis, but the conversion of 
oxaloacetate to malate and then oxidation of malate to pyruvate, is another source of 
NAPDH. Pyruvate produced in this fashion may then return to the mitchondria to 
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continue the cycle. The observed down regulation of the enzyme alpha enolase, which 
catalyzes the final step of glycolysis could be due to the cyclical recycling of pyruvate 
through the steps described. If glucose is not being used for production of pyruvate, it 
may be spared for the synthesis of lactose or converted to glycerol for milk fat. 
 
Heat Shock Proteins 
Several heat shock proteins (HSP) were identified as changing in abundance between 
states of pregnancy and lactation in the isolated mammary epithelial cell populations. 
HSPs are molecular chaperones that facilitate the correct folding of proteins and are 
associated with function and formation of the cytoskeleton. It is not surprising that the 
differentiation of the mammary epithelium, in vivo, would require structural re-
organization, which may be facilitated by this family of proteins.  
 
Cytoskeletal Proteins 
Structurally, we saw a down-regulation in keratins 8 and 18, which are associated with 
epithelial differentiation and filament reorganization, respectively. As differentiated cells 
were isolated from mice at peak lactation, it is expected that cells would be fully 
differentiated and not undergoing major structural changes they would during pregnancy 
and proliferation. Coincidentally, keratin 18, or CK18, was the marker of epithelial origin 
selected for use in flow cytometry (see appendix). It is interesting that we saw a down-
regulation of this protein, as previous studies suggested use of this antibody due to 
uniform expression in luminal epithelial cells (O’Hare, 1991). Keratin 5 however, was 
up-regulated, which is interesting as this is also a filament associated with the process of 
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differentiation which these cells should no longer be undergoing. This change in specific 
intermediate filaments is a point of differentiation that deserves deeper research. 
 
Nuclear Proteins 
Within the group of resident nuclear proteins that were identified to change, there were 
seven examples of heterogeneous nuclear ribonucleoproteins (hnRNP) and all decreased 
in abundance after differentiation. These particles are generally bound to pre-mRNA to 
signal that the mRNA is not yet ready to be translocated to the cytoplasm. Once the 
correct splicing has occurred, mature mRNA may leave the nucleus, and hnRNPs remain 
bound to spliced-out introns, then signaling for degredation (Papadopoulou, 2012). The 
down-regulation of every hnRNP we detected to change signifies either a reduction in the 
mRNA for genes with which these specific hnRNPs are associated, or a change in the 
way the differentiated cell directs splicing and mRNA processing. 
 
Pre-mRNA processing factor 19, isoform 2, which was down regulated in the lactating 
mouse mammary epithelium, was also down regulated in differentiated MAC-T cells, 
indicating that this protein may play a universal role in the mammary epithelial cell 
specifically during proliferation. In the mouse brain, expression of the beta isoform of the 
pre-mRNA processing factor 19 gene (Prf19b) caused differentiation of neuronal cells, 
but inhibited differentiation of astroglial cells indicating that alternative splicing of this 
gene plays a very specific role in cell fate decision (Urano, 2006). Perhaps, this isoform 
of the Prf19 gene is also required for the differentiation of mammary epithelial cells. 
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CHAPTER 4 - Summary  
 
These experiments present the same cell type from two different species utilizing very 
different metabolic processes that overall, result in a very similar outcome: lactogenesis. 
In other words, there are multiple routes to the same endpoint, and the pathways taken to 
differentiation could possibly be determined by the diet, absorption and subsequent 
nutrients available to the mammary gland.  
 
The first experiment presented within this document compared the protein expression 
profiles of MAC-T cells from before and after induced in vitro differentiation. The data 
produced through this experiment supported earlier research from our lab which not only 
revealed a direct effect of growth hormone on MAC-T, but suggested the effect may be 
similar to the changes occurring naturally during differentiation of the cell. By observing 
the changes to the proteome that occurred between proliferation and differentiation of 
MAC-T cells, we not only confirmed that there are several similarities between 
differentiation and GH treatment, but also uncovered a host of proteins that we did not 
expect to change. The new list of identified proteins provides a great deal of novel 
information about the mammary epithelium and the molecular processes that are possibly 
involved in lactogenesis.  
 
The second study was designed in attempt to provide an in vivo comparison to this 
experiment, while simultaneously offering insight into the inherent differences between 
mammary glands from ruminant and rodent animals. As the diets and overall metabolic 
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systems in these two species are drastically different, it is interesting to see evidence that 
those differences are mirrored on the molecular level in the way mammary epithelial cells 
use or spare certain nutrients, depending on availability, to efficiently synthesize all of 
the essential components of milk.  
 
While the differing proteins between primary MEC isolated before and after the initiation 
of lactation provide an interesting basis for further study, it is important to remember that 
the two stages at which we isolated our protein samples do not provide a progressive 
picture of the changes occurring within the mammary epithelium. These data afford a 
great number of possibilities for studies to be developed providing a clearer picture of 
individual pathways and metabolic changes by observing additional time-points or by 
employing more specific, quantitative technologies. Western blotting is an excellent tool 
for measuring specific proteins of interest and would negate the challenge of missing 
low-abundance proteins or misguided analysis due to post-translational modifications, 
which are possible with our methods of 2D electrophoresis. However, there are added 
challenges to the Western blot such as antibody specificity, difficulty identifying 
important post-translational modifications and statistical analyses that would require 
careful consideration. Additionally, adding other developmental stages, such as pre 
versus post puberty and pre versus post established pregnancy would be interesting to 
study in comparison to our findings. 
 
Some of the data collected in these experiments has paralleled previous research in 
mammary gland biology, some appears to challenge the current dogma and some has 
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incited our curiosity in pathways never before explored in the mammary epithelium. 
While much necessary investigation still remains to make clear the roles of certain 
proteins and pathways in the evolution to a lactogenic phenotype, the analysis of these 
extensive protein lists may provide a platform from which further research may be based. 
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APPENDIX 
Flow Cytometry 
Although we attempted to verify the epithelial origin of primary cells isolated from 
pregnant and lactating mice through application of flow cytometry, our efforts were 
relatively unsuccessful. Cytokeratin 18 (CK18) was selected as a positive marker as it is a 
cytoskeletal filament associated specifically with luminal-epithelial cells and not 
squamous, myoepithelial cells or fibroblasts which are possible contaminating cell types 
in a primary mammary epithelial cell isolation such as this one (O’Hare, 1991). 
Additionally, CK18 and had previously been demonstrated to be uniformly expressed by 
MAC-T populations (Zavizion, 1995).  
 
A FITC-conjugated primary anti-mouse CK18 antibody was purchased from Abcam 
(Cambridge, MA). 
 
Primary cells isolated for proteomic analysis from pregnant and lactating mice were 
thawed from storage in liquid nitrogen. Additionally, HC11 cells (an immortal mouse 
mammary epithelial cell line) were thawed and used as a positive control. 3T3 cells were 
selected as a negative control as this fibroblast cell line is murine in origin, but should not 
express CK18. Remaining cells were fixed and permeabilized through incubation in 
100% methanol at -20°C for 30 minutes. Cells were then centrifuged and rinsed in PBS. 
CK18 antibody was diluted from 100ug/ml to 10ug/ml in 3% Bovine Serum Albumin 
(BSA) and then to a final concentration of 1ug/ml in cell suspension. All cells were 
incubated in the dark at 4°C for 30 minutes. Control cells of each variety were incubated 
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simultaneously under the same conditions with an equal volume of 3% BSA containing 
no antibody. After incubation, cells were washed 3x through centrifugation at 400 x g for 
5 minutes in PBS. Each pellet was diluted to a final concentration of <500 cells/ul before 
analysis by flow cytometry. Levels of florescence emitted by each cell corresponded with 
the expression of CK18. Fluorescence data between cell types was overlaid and 
compared with viability counts to estimate the percentage of epithelial cells isolated. 
  
Results 
A.     
Figure ___. Cells isolated from pregnant mice that were (A) plated overnight were 87% 
viable and stained positively with CK18 FITC conjugated antibody (solid peaks) as 
compared to the negative control (3T3 fibroblasts), overlaid in the image. (B) Cells tes
directly after thawed from liquid N were only 40% viable and consequently, less 
fluorescence was measured as compared to the negative control. 
A.     
Figure ___. Cells isolated from lactating mice that were (A) plated overnight were 78% 
viable and stained positively with CK18 FITC conjugated antibody (solid peaks) as 
compared to the negative control (3T3 fibroblasts), as shown by the dark line overlaid in 
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  B. 
 
  B. 
 
 
ted 
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the image. The lighter overlay represents two peaks of fluorescence of the cells from 
pregnant mice after the same culture period. (B) Cells tested directly after thawed from 
liquid N were only 41% viable and consequently, less fluorescence was measured as 
compared to the negative control.  
 
 
  
 
